Author details 1-Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Seewartenstr. 10, 20459, Hamburg, Germany
Introduction
Bronchial asthma and chronic obstructive pulmonary disease (COPD) are common conditions and are the dominating obstructive airway diseases in the general population.
Work-related asthma (WRA) including irritant-induced occupational asthma (OA)
Occupational asthma is defined as a chronic inflammatory disorder of the airways with recurrent episodes of coughing, wheezing, chest tightness, dyspnea, shortness of breath at rest, and reversible airflow limitations caused by a particular occupational environment [1-3].
The available epidemiological and comparative studies and reviews provide evidence that occupational agents cause 5 - 25% of all asthma cases [1-23]. Besides these evident occupational asthma (OA) cases, there is probably an even larger population of sufferers of work-aggravated asthma [24-26]. The latter population shows an objective worsening of pre-existing asthma or non-occupational asthma that develops in parallel with causative conditions encountered in the workplace (Figure [figure omitted; refer to PDF] ).
Figure 1
Work-related asthma is divided into occupational asthma and work-aggravated asthma
Work-related asthma is divided into occupational asthma and work-aggravated asthma.
[figure omitted; refer to PDF]
Occupational agents eliciting bronchial asthma, i.e. OA, comprise occupational allergens, with their well-defined etiological role and IgE-mediated pathomechanism, as well as occupational agents with unknown pathomechanisms and occupational respiratory irritants, mainly representing low molecular weight chemicals (LMW; <5000 Daltons) causing irritant-induced OA (Figure [figure omitted; refer to PDF] ). The latter agents may also elicit occupational COPD (see chapter 1.2) and include chlorine, acids, welding fumes, as well as isocyanates. The etiological role of such low molecular chemicals has not yet been completely clarified, primarily because of the lack of specific diagnostic tests.
Figure 2
Subgroups of OA
Subgroups of OA.
[figure omitted; refer to PDF]
There is sparse data available on causes and frequencies of irritant-induced COPD and work-aggravated asthma. Therefore, this work focuses on irritant-induced OA.
There is increasing evidence that irritant-induced OA can be further subdivided into three subcategories as outlined in Table 1 [27-29].
Table 1
Subcategories of irritant-induced OA
Subcategories of irritant-induced OA | Exposure concentration | Duration of exposure |
Reactive airways dysfunction syndrome (RADS) | Extremely high, > OEL | ≤1 day |
Not so sudden onset of irritant-induced OA | Moderate, around OEL | >1 day <4 months |
Low dose irritant-induced OA | Low, below OEL | >4 months |
OA = Occupational asthma, OEL = Occupational Exposure Limit.
Many case reports, case series and a few cross-sectional studies demonstrate that a single short-term accidental massive exposure or several short-term high-level exposures to a respiratory irritant can cause asthma within 24 hours without a latency period. Brooks et al. [30] defined this disorder as "reactive airways dysfunction syndrome" (RADS). This term was later extended to irritant-induced OA from multiple, somewhat lower, exposure incidents with a less sudden onset that were also shown to cause this disorder [27-36].
Furthermore, there is evidence that a susceptible subgroup of subjects mainly atopics with non-specific bronchial hyperresponsiveness (NSBHR) suffering from irritant-induced OA, is also affected by chronic exposures to relatively low concentrations of irritant gases, fumes or aerosols [27-38]. This disorder has been called "low-dose irritant asthma" (or "low-dose RADS"). Corresponding studies indicate respiratory effects including asthma from mainly chronic or repeated exposure to a single irritant or a mixture. Demonstrably causative concentrations of a particular irritant are often below their occupational exposure limits (OELs) or permissible exposure limits (PELs). Such irritant examples include swine confinement facilities [39-40], exposures to cleaning agents [12-41], solvents, ozone, endotoxin, formaldehyde, quaternary ammonium compounds, chlorine, bisulfite and SO2 , or acid mist [36-44], diesel exhaust [10-46], fumigant residues [47], dusts in the textile paper, mineral fiber or construction industries or in mines [48-51], as well as a proportion of cases of potroom asthma [52] and meatwrappers' asthma [53]. Asthma in cold-air athletes may also be relevant [54-55]. A previous summary of the literature on respiratory effects from asthma due to irritants below their OELs/PELs is available [56]. Many of the earlier exposure limits have been lowered repeatedly in the light of subsequent clinical or epidemiological findings on their respiratory effects. Other limits remain obstinately high given their known irritative effects and/or that they are based on sparse data [56]. Accordingly, adherence to OELs/PELs does not preclude the onset of WRA in susceptible subjects.
The broader definition of these disorders (as used in the legal definition in Germany) includes all irritant-induced obstructive airway diseases irrespective of their causative concentrations and reversibility, i.e. irritant-induced occupational asthma as well as COPD.
Frequency of OA
OA has become the most prevalent occupational lung disease in developed countries [57-58] and it is one of the most frequent diagnosis among occupational diseases in general [59]. The annual incidence of OA is in the range of 50 per million with extremes up to 250 per million workers and more than 1,300 per million in specific workplaces [57-60]. As already mentioned there is evidence that occupational agents cause 5 - 25% of of all asthma cases. However, complete registries of OA do not exist and therefore the true frequency of the disease is unknown. Ameille et al. [61] and Fernández-Nieto et al. [59] stated that OA is underestimated among occupational diseases, because many OA cases are not subjected to appropriate diagnostic tests.
Irritant-induced OA is reported to occur in approximately 5 -18% of all OA cases, being the second most common form of OA after allergic OA [36-62].
Chronic obstructive pulmonary disease (COPD) due to occupational exposure
The diagnosis of COPD is based on chronic productive cough, airflow limitation that is usually not fully reversible, and a progressive, abnormal inflammative response of the lungs mostly caused by long-term smoking and by other noxious particles or gases [1].
During ongoing causative exposures (e.g. smoking particles, droplets and/or gases), airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lungs. Patients with COPD have greater number of neutrophils and alveolar macrophages in bronchoalveolar lavage fluid than healthy non-smokers [63]. Sites of emphysema, which are frequently found in COPD patients, contain large numbers of lymphocytes, and the extent of lymphocyte accumulation correlates with reduction of FEV1 .
In their summaries of the literature, Hnizdo et al. [64], Trupin et al. [65] and Balmes et al. [1] found an occupational contribution in about 15% of COPD cases.
Occupational COPD is identified on epidemiological basis, by observing increased frequencies of COPD among certain working groups [66], e.g. in construction workers [2]. Some occupational exposures (e.g. welding fumes, aluminium, potroom fumes, and cadmium) may cause COPD associated with emphysema [67-68].
At later stages of OA, the condition of some subjects does not improve over weekends or during holidays and coincides with symptoms of COPD patients. This observation also applies to non-occupational obstructive airways diseases [69-70] and indicates that a group with changing diagnoses as well as with some overlap between OA and occupational COPD, does exist [66-73].
Background and objective
WRA and occupational COPD are serious and sometimes fatal diseases, which can lead to ill health, inability to work and lost productivity [1-76]. They represent a huge economic burden to the society. For details see Additional file 1: Online Supplement "Economic burden".
Additional file 1
Economic burden.
Click here for file
The objective of this study is to summarize present knowledge on respiratory irritants causing obstructive airway diseases in humans in the occupational setting and to provide a rating of the strength of evidence for each irritant which has not been previously available.
Methodology
A systematic review of the literature on occupational irritant-induced OA and occupational COPD due to occupational irritants was conducted. We considered asthma-inducing irritating agents as well as those reported to cause occupational COPD and related disorders, where obstructive ventilation patterns were demonstrated in clinical investigations, cross-sectional studies, cross-shift and/or in long-term exposure studies. Irritating gases mainly occurring in the general environment, such as ozone, and inorganic dusts, including silica, talcum, silicates and other fibers known to cause pneumoconioses, were not considered even though exposure to them is frequently associated with mixed ventilation patterns.
Definitions used
Occupational COPD: chronic bronchitis symptoms and non-reversible airflow limitation due to particular occupational environment (if lung function data was available; otherwise, clinical diagnosis as given by the authors is cited).
Occupational asthma: episodes of shorteness of breath due to particular occupational environment and reversible airflow limitation (if lung function data was available; otherwise, clinical diagnosis as given by the authors is cited).
Obstructive ventilation pattern: we applied reference values of FEV1 /FVC from Brändli, Schindler et al. 2000 [77].
Information sources and selection criteria
Occupational respiratory irritants
To identify the evidence of irritants of the respiratory tract, all agents denoted as "may cause respiratory irritation" by the phrase H335 (previous code R37) and "may cause allergy or asthma symptoms or breathing difficulties if inhaled" H334 (previous code R42) [78] and/or as "irritants" by American Conference of Governmental Industrial Hygienists [79] were initially listed [80]; later this list was compared with results of our database search (see below).
Database search.
We searched for publications reporting investigations exclusively in humans (i.e. animal or in-vitro research was excluded). To be included, the publications had to deal with subjects occupationally exposed to airway irritants.
MEDLINE®-Database was searched with PubMed® from its inception up to December 2007 with the following medical subject headings (MeSH) combinations for each single agent:
"Agent "[MeSH] AND "Humans"[MeSH] AND (("Asthma"[MeSH] OR "Asthma/chemically induced"[MeSH] OR "Asthma/immunology"[MeSH]) OR "Pulmonary Disease, Chronic Obstructive"[MeSH] OR "Lung Diseases, Obstructive/*chemically induced"[MeSH] OR "Respiratory Function Tests"[MeSH]) AND ("Accidents, Occupational"[MeSH] OR "Occupational Exposure"[MeSH] OR "Occupational Diseases"[MeSH] OR "Occupational Diseases/chemically induced"[MeSH])).
If more than 20 publications per agent were found, the search was more specified:
"Agent "[MeSH] AND "Humans"[MeSH] AND ("Cohort Studies"[MeSH] OR "Case-control Studies"[MeSH] OR "Case-control Studies"[All Fields] OR "Longitudinal Studies"[MeSH] OR "Longitudinal Studies"[All Fields] OR "Cross-Sectional Studies"[MeSH] OR "Cross-Sectional Studies"[All Fields] OR "Epidemiologic Studies"[MeSH] OR "Epidemiologic Studies"[All Fields] OR "Case Reports"[Publication Type] OR "Meta-Analysis"[MeSH] OR "Meta-Analysis"[All Fields]) AND "adverse effects"[Subheading] AND (("Asthma"[MeSH] OR "Asthma/chemically induced"[MeSH] OR "Asthma/immunology"[MeSH]) OR "Pulmonary Disease, Chronic Obstructive"[MeSH] OR "Lung Diseases, Obstructive/*chemically induced"[MeSH] OR "Respiratory Function Tests"[MeSH]) AND ("Accidents, Occupational"[MeSH] OR "Occupational Exposure"[MeSH] OR "Occupational Diseases"[MeSH] OR "Occupational Diseases/chemically induced"[MeSH])).
Reference list screening
We also considered references in the identified already existing 13 systematic reviews or overviews of causes of work-related asthma or COPD and tried to combine results of both approaches.
Occupational diseases statistics
Further, we considered the following occupational diseases statistics based either on statutory surveillance or registration systems: SWORD 1994-1997 [81-83]; SHIELD 1993 [74]; SORDSA 2001 [84]; SENSOR 2003 [85]; Dokumentation der Berufskrankheiten 2007 (BK-DOK) [86].
Conditions
Four different conditions were accepted for inclusion:
1. Irritant-induced OA including RADS. Asthma caused by single or multiple occupational exposures to airway irritants; de novo irritant-induced OA. Asthma within 24 hours without a latency period caused by short-term high-level exposures to a respiratory irritant known as acute irritant-induced asthma, or as RADS [30].
2. Work-aggravated (exacerbated) irritant-induced OA. Pre-existing or concurrent asthma worsened by work factors [24]. Subjects with work-related asthmatic symptoms, if not differentiated whether new-onset or work-aggravated.
3. Occupational COPD. On epidemiological basis, identified by observing increased frequencies of COPD among certain working groups [66].
4. Obstructive ventilation pattern. Studies about irritant agents, where obstructive ventilation patterns in occupational settings were reported.
Methodological selection criteria
Publications with one of the following study designs were included: Systematic reviews of cohorts, case-control or cross-sectional studies, cohort studies (prospective/retrospective), case-control studies, cross-sectional studies, surveys.
Non-analytic1a studies (i.e. case series, follow-up of cases or case reports) were only included when for an agent no studies with one of the above mentioned designs had been identified.
Publications were included when they met any of the following criteria: examining the frequency of irritant-induced OA or asthmatic work-related symptoms in occupationally exposed groups or individuals, reporting the causative role of the specific agent or mixture of agents for irritant-inducing WRA or COPD.
Studies were included when they applied any of the following diagnostic tools: description of work-related asthmatic symptoms (questionnaire), lung function test (LFT), testing for non-specific bronchial hyperresponsiveness (NSBHR) by means of methacholine, histamine or other pharmacological agents, serial spirometry or expiratory peak flow (PEF) monitoring or supervised exposure testing in the workplace, challenge with the help of lung function measurements (SFT), specific inhalation challenge testing (SIC), clinical diagnosis of OA by an expert (occupational or pulmonary physician), and exposure to an irritant agent.
Publication period: No restriction for publication dates were made, last updates were between 5th and 15th June 2012.
Language: English, German, Spanish, Italian or French.
Methodological studies, e.g. on effects of study design and subsequent procedures, and studies with non-occupational disorders were excluded. Publications about occupational agents which do not have an irritant effect on the respiratory tract (e.g. about IgE-sensitizing agents) or with unrelated issues (e.g. studies on immunological questions) were also excluded.
Assessment of study quality
The principal study characteristics and study results were systematically extracted using an extraction sheet (see Additional file 2: Table S1A of online supplement "Methodology").
Additional file 2
"Methodology" Selection criteria, information sources, strength of evidence. Table A: Data extraction and synthesis. Table B. Quality assessment of individual study. Table C - The revised Scottish Intercollegiate Guidelines Network (SIGN) grading system (modifications are given in italics) [87]. Table D The Royal College of General Practitioners (RCGP) three-star system [88] used by the British Occupational Health Research Foundation [3-574] (modifications are given in italics).
Click here for file
We assessed study quality with the help of a check list (see Additional file 2: Table S1B of online supplement "Methodology"). The evidence level of each study was graded according to the revised Scottish Intercollegiate Guidelines Network (SIGN) grading system [87]. Since population-based randomized assignment to different levels of irritant exposure are unethical, no randomised controlled trials (RCTs) could be expected on this topic and, thus, no level 1 evidence (as defined by the revised SIGN grading system) [87] would be available. In order to achieve more differentiation among lower evidence grades, we modified the SIGN grading system and added an additional grade (3+) (see Additional file 2: Table S1C of online supplement "Methodology").
Details of the modified RCGP [88] grading system are given in the online supplement "Methodology", Additional file 2: Table S1D.
Results
Overview on publications retrieved
The database search (MEDLINE/ PubMed) yielded 383 potentially relevant publications. 480 additional potentially relevant publications were retrieved from the reference lists of 13 systematic reviews or overviews [2-97], from occupational diseases routine statistics (SWORD 1994-1997 [47-83]; SHIELD 1993 [74]; SORDSA 2001 [84]; SENSOR 2003 [85]; BK-DOK 2007 [86], and from the library of the Institute of Occupational Medicine, Hamburg. Alltogether, the different search approaches yielded a total of 474 relevant studies, including an extreme early study from the year 1932 [98]. (See selection flow diagram, Figure [figure omitted; refer to PDF] ).
Figure 3
Flow diagram demonstrating the source of references
Flow diagram demonstrating the source of references.
[figure omitted; refer to PDF]
Most (n = 337) of the 474 relevant publications were identified through hand searching (i.e. reference list checking of systematic reviews and from our library database).
The 474 publications refer to 131 individual agents, 46 to "mixed" agents and 11 to work-sites or professions reported to cause OA and/ or occupational COPD.
Diagnostic aspects
Many different ways of confirming irritant-induced OA were used, with specific inhalation challenge (SIC) and lung function tests (LFT) being the most reliable diagnostic aids.
SIC was used as the "gold standard" in confirming OA mainly in non-analytical studies (n = 189 studies, i.e. 72% of non-analytical studies). Only few (n = 16, i.e. 7.5% of analytical studies) cohort or case-control reported diagnostic confirmation with SIC.
Another frequently used (n = 191) diagnostic method for OA or occupational COPD was lung function testing (LFT); showing an obstructive ventilation pattern and/or NSBHR related to occupational exposures, mostly in combination with WRA symptoms.
Exclusively self-reported asthma symptoms or physician reported asthma as documented in questionnaires as an alternative diagnosis for OA was used in 36 studies.
Other studies (n = 44) had not clear diagnosis of OA or occupational COPD but reported obstructive ventilation pattern. The number of subjects with asthma symptoms and frequencies of obstructive ventilation patterns and/or NSBHR are provided for each study (see Additional file 3: Table S2E of online supplement "Results").
Additional file 3
"Results" Table E overview on publications and SIGN grading of reporting OA or occupational COPD due to irritants. X. Baur, P. Bakehe, H. Vellguth http://www.eomsociety.org = > Knowledge Center.
Click here for file
Irritant-induced OA as outcome
Irritant-induced OA was the focus of most studies and was the predominant diagnosis.
RADS, as a subgroup of irritant-induced OA, was reported to be due to 47 different agents, with the most prevalent being the World Trade Center disaster in 2001 (n = 7 studies), chlorine (n = 11), cleaning agents (n = 18) and isocyanates (n = 46). These were followed by disorders, caused by metam sodium (n = 17), ammonia (n = 11), diesel exhaust (n = 10), acids (n = 9), solvents (n = 8), sulfur dioxide (n = 7), dinitrogen tetraoxide (n = 6), hydrogen chloride (n = 4), smoke (fires, pyrolysis products) (n = 4), chlorofluorocarbons (n = 4), spray paint (n = 3), tear gas (n = 3), bromine (n = 2), dichlorvos (n = 2), sodium azide (n = 2), acrylates (n = 1), amprolium hydrochloride (n = 1), phthalic anhydride (n = 1), bromochlorodifluoromethane (n = 1), bromotrifluoromethane (n = 1), chloramine T (n = 1), chromate (n = 1), hydrazine (n = 1), hydrogen fluoride (n = 1), methylmercaptan (n = 1), phosgene (n = 1), uranium hexafluoride (n = 1), airbag content (n = 1), bleaching agent (n = 1), floor sealant (n = 1), fumigant (n = 1), metal coat remover (n = 1), metal oxide fume (n = 1), pesticides (n = 1), refractory ceramic fibers (n = 1), swine confinement (n = 1).
The majority of asthma-inducing agents elicited OA after prolonged exposure and rarely after a single exposure.
Work-aggravated asthma was of less importance in the literature and occurred in only a few studies [30-104].
Occupational COPD as outcome
Ten agents and five professions or work-sites were reported to cause occupational COPD, as shown in Table 2.
Table 2
Agents and professions showing evidence of occupational COPD
Agents, number of studies (n) | Work-sites or professions, number of studies (n ) |
[white circle] ammonia (1) [white circle] cement dust (4) [white circle] chlorine (1) [white circle] cleaning agent (1) [white circle] mustard gas (1) [white circle] diesel exhaust (2) [white circle] environmental tobacco smoke(1) [white circle] isocyanate (1) [white circle] smoke (1) [white circle] sulphur dioxide (1) | [white circle] construction work (3) [white circle] swine confinement (1) [white circle] farming (1) [white circle] foundry (1) [white circle] metallurgical industry workers (1) |
COPD = Chronic obstructive pulmonary disease.
As already mentioned, occupational COPD was not specifically addressed in most of the studies. Some describe respiratory symptoms, such as chronic bronchitis (n = 21), which may be indicative of COPD. One of the few studies which specifically focused on COPD, was a large retrospective cohort study on diesel exhaust which caused a significantly increased COPD mortality in railroad workers after the introduction of diesel engines in 1945 [105-106]. Construction work was identified as a cause of occupational COPD in 2 publications [8-107].
Evidence level of the literature
Some publications investigated more than one irritant agent and thus have been considered several times in our study.
262 of the 474 publications were non-analytic studies and were rated according to SIGN as 4, 3 or 3+ and consisted of case reports (n = 228), case series (n = 63), and occupational diseases statistics (n = 33) and reviews of that kind of studies (n = 7). The other publications reported analytical studies and were rated according to SIGN as 2+ (n = 15), 2- (n = 103), or 3+ (n = 83).
The highest level was 2+, indicating a well conducted analytical study (case control or cohort studies) with a low risk of confounding or bias (n = 15 studies). Other studies with a similar design had a higher risk of confounding or bias and were individually rated lower by SIGN grading of 2- (n = 30 studies). Most of the other analytical studies were rated with a SIGN grade of 2-, because their design (cross-sectional or longitudinal study) was limiting (n = 82 studies). Cross-sectional studies or longitudinal studies, e.g. those with high risk of confounding or bias, were rated even lower with 3/ 3+ (n = 35 studies). A couple of study designs were difficult to classify epidemiologically, including those which were surveys, mostly with very low analytical evidence, rated 3/ 3+ (n = 53 studies), or larger surveys with a lower risk of confounding or bias, which were graded with 2- (n = 4 studies).
Investigations involving dose-response relationship as a form of scientific evidence were performed in 30 out of 474 studies analyzed [68-133].
Another assessment of the level of evidence found in individual studies is to consider their OR for irritant-induced OA or occupational COPD; this was done in 39 publications [15-156].
Strength of evidence per agent, work-site or profession
The outcome for each agent causing OA or occupational COPD was graded according to the modified RCGP three-star system to classify the strength of evidence of its causative role in irritant-induced OA/ occupational COPD. The strongest evidence achieved was two stars "**" (indicating a moderate strength of evidence provided by generally consistent findings in fewer, smaller or lower quality scientific studies) for 17 (mixed) agents, work-sites or professions. For six of them (chlorine, platinum salts, environmental tobacco smoke, welding fumes, construction work, World Trade Center disaster in 2001), this level was based on well- conducted studies with low risk of confounding and/or bias (SIGN 2+). For eleven of these 17 (mixed) agents, SIGN levels of individual studies were lower (benzene-1, 2, 4-tricarboxylic acid-1,2-anhydride [trimellitic anhydride], cobalt, isocyanates, cement dust, grain dust, animal farming (pig, beef/veal, dairy, poultry), or swine confinement.
Low to moderate scientific evidence - provided by generally consistent findings in fewer, smaller or lower quality analytical studies, based on questionnaires or other inadequacies, i.e. "*[*]" - was found for 12 agents (phthalic anhydride, glutaraldehyde [glutaral], sulfur dioxide, cotton (dust, raw) CNT 750, potroom aluminum smelting, farming (various) or foundry), smoke (fires, pyrolysis products), pesticides (not specified), cleaning agents (not specified), ceramic production (dust), health care workers.
Limited or contradictory evidence - provided by only one analytical study or inconsistent findings in multiple scientific studies, i.e."*" - was identified for 39 agents, and after down-grading because of inadequate methodological aspects, i.e. "[*]" on three occasions. For the majority of agents, only non-analytical studies were reported for ≥ 5 cases, i.e. "(*)" or less than 5 cases, i.e. "-". When only non-analytical studies were available, the strength of evidence for the agent was raised if at least 5 cases were identified by the case reports/ case series or occupational disease statistics for which proof of irritant-induced OA or occupational COPD existed. The strength of evidence reached when only non-analytical studies were available ranged from "very limited or contradictory evidence" in 29 studies, i.e. "(*)", to "no scientific evidence" "-" 94 times. (see Tables 3 and 4 and Additional file 3: Table S2E of online supplement "Result").
Table 3
Overview of individual agents causing irritant-induced OA or occupational COPD
Agent CAS | Strength of evidence (modified RCGP three star grading) | Number of studies per agent | References |
Acids | |||
", acetic | * | 3 | [108-158] |
64-19-7 | |||
", not specified | (*) | 2 | [30-37] |
", dodecanedioic | - | 1 | [159] |
693-23-2-1 | |||
", various | - | 1 | [35] |
", " (hydrochloric, hydrofluoric, nitric, perchloric, sulfuric) | - | 1 | [160] |
", hydrochloric | (*) | 6 | [35-162] |
7647-01-0 | |||
", hydrofluoric | - | 1 | [163] |
7664-39-3 | |||
", sulfuric | * | 3 | [99-164] |
7664-93-9 | |||
Acrylates | |||
", not specified | - | 1 | [165] |
", alkyl cyanoacrylates | (*) | 4 | [166-169] |
", cyanoacrylate glue | - | 1 | [170] |
", " [loctite] | * | 4 | [44-172] |
53858-53-0 | |||
", methacrylates | * | 1 | [134] |
", methyl 2-cyanoacrylate | - | 3 | [166-173] |
137-05-3 | |||
", methylmethacrylate | - | 2 | [169-174] |
80-62-6 | |||
Aluminum salts | * | 1 | [100] |
aluminum fluoride: 7724-18-1 | |||
aluminum sulfate: 10043-01-3 | |||
2-Aminoethanol [2-ethanolamine] | - | 1 | [175] |
141-43-5 | |||
Amino-ethyl-ethanolamine | - | 1 | [176] |
111-41-1 | |||
3-Amino-5-mercapto-1,2,4-triazole | (*) | 1 | [177] |
16691-43-3 | |||
Ammonia | * | 6 | [41-182] |
7664-41-7 | |||
Ammonium chloride (triple salt) | - | 1 | [183] |
12125-02-9 | |||
Ammonium thioglycolate | - | 1 | [184] |
5421-46-5 | |||
Amprolium hydrochloride | - | 1 | [185] |
137-88-2 | |||
Anhydrides | |||
", various | * | 2 | [186-187] |
", dioctyl phthalate | - | 1 | [188] |
117-81-7 | |||
", hexahydrophthalic | - | 1 | [189] |
37226-48-5 | |||
", himic | - | 1 | [190] |
2746-19-2 | |||
", maleic | - | 2 | [191-192] |
108-31-6 | |||
", methyltetrahydrophthalic | - | 1 | [193] |
26590-20-9 | |||
", phthalic anhydride | *[*] | 5 | [194-198] |
85-44-9 | |||
", pyromellitic dianhydride | - | 1 | [199] |
89-32-7 | |||
", tetrachlorophthalic anhydride | * | 4 | [200], [201], [202], [203] |
117-08-8 | |||
", benzene-1, 2, 4- tricarboxylic acid 1,2-anhydride [trimellitic anhydride] | ** | 5 | [197-207] |
552-30-7 | |||
Aziridine, polyfunctional | (*) | 2 | [208-209] |
64265-57-2 | |||
Azobisformamide [azodicarbonamide] | * | 5 | [210-214] |
123-77-3 | |||
Benzalkonium chloride (fumes) | - | 2 | [215-216] |
8001-54-5 | |||
1, 2-Benzisothiazoline-3-one (fumes) | - | 1 | [217] |
2634-33-5 | |||
Bisulfite, SO2 | - | 1 | [37] |
SO2: 7446-09-5 | |||
Bromine, hydrobromic acid | - | 1 | [218] |
Bromochlorodifluoromethane (Halon 1211) | - | 1 | [101] |
353-59-3 | |||
Bromotrifluoromethane (Halon 1301) | - | 1 | [219] |
75-63-8 | |||
Cadmium (fumes) | * | 4 | [68-222] |
7440-43-9 | |||
Calcium carbonate [chalk powder] | - | 1 | [110] |
Calcium oxide | - | 1 | [35] |
1305-78-8 | |||
Captafol (chlorinated thiocarboximide fungicide) | - | 1 | [223] |
2425-06-1 | |||
Carbon black dust | * | 1 | [224] |
1333-86-4 | |||
Chloramine T (powder dust) | (*) | 5 | [225-229] |
7080-50-4 | |||
Chlorhexidine | - | 1 | [230] |
55-56-1 | |||
Chlorine | ** | 11 | [35-239] |
7782-50-5 | |||
Chromate (not specified) | (*) | 9 | [240-241] [98-247] |
[see also cement] | |||
Cobalt | ** | 15 | [74-259] |
7440-48-4 | |||
3-(Diamino-amino)propylamine 3-(dimethylamino)propylamine] | (*) | 1 | [260] |
109-55-7 | |||
Diamine, aliphatic + cycloaliphatic (hardener) 2855-13-2 (isophorone diamine) | - | 1 | [261] |
Diazonium tetrafluoroborate 14239-22-6 | - | 2 | [262-263] |
Dichlorodiethyl sulfide [mustard gas] +505-60-2 | (*) | 1 | [264] |
Dichlorvos (organophosphate) | - | 2 | [265-266] |
62-73-7 | |||
Diethanolamine | - | 1 | [267] |
111-42-2 | |||
2-Diethylaminoethanol [diethyl aminoethanol] | (*) | 1 | [268] |
100-37-8 | |||
2-Dimethylaminoethanol [dimethyl ethanolamine] | - | 2 | [269-270] |
108-01-0 | |||
Diinitrogen tetraoxide [dinitrogentetroxide] | (*) | 1 | [271] |
10544-72-6 | |||
Ethylenediamine [ethylene diamine] | * | 6 | [168-275] |
107-15-3 | |||
Ethylene oxide | - | 2 | [276-277] |
75-21-8 | |||
Formaldehyde (gas, dust) | * | 9 | [278-283], [284-285] |
50-00-0 | |||
Freon , (freon-22) | - | 2 | [286-287] |
Glutaraldehyde [glutaral] | *[*] | 9 | [74-294] |
11-30-8 | |||
Hexachlorophene | - | 1 | [295] |
70-30-4 | |||
Hexamethylenetetramine | * | 3 | [184-297] |
100-97-0 | |||
Hydrazine | - | 1 | [30] |
302-01-2 | |||
Iridium salt | - | 1 | [298] |
Isocyanates, isocyanurate | |||
", various (HDI, MDI, TDI) | ** | 11 | [57-303] |
", Diphenylmethane diisocyanate [MDI] | ** | 7 | [304-310] |
5873-54-1 | |||
", " prepolymers | - | 1 | [311] |
", Hexamethylene diisocyanate [HDI]; plus isodurane Diisocyanate | (*) | 3 | [312-313] |
822-06-0 | |||
", HDI biuret plus | [314] | ||
4035-89-6 | |||
", 3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate [isophorone diisocyanate, IPDI] | - | 1 | [315] |
4098-71-9 | |||
", Methyl isocyanate [MIC] | * | 6 | [316-321] |
624-83-9 | |||
", 1,5-Naphthylene diisocyanate [NDI] | (*) | [46] | [322-324] |
3173-72-6 | |||
", Polymethylene polyphenyl isocyanate | * | 1 | [325] |
9016-87-9 | |||
", Toluene diisocyanate, TDI 2,4: 584-84-9; | ** | 12 | [35-334] |
2,6:91-08-7 | |||
", Triglycidil isocyanurate | - | 1 | [335] |
2451-62-1 | |||
", Triphenylmethane triisocyanate | - | 1 | [336] |
Isothiazolinone | - | 1 | [337] |
55965-84-9 | |||
Lauryl dimethyl benzyl ammonium chloride | - | 1 | [338] |
139-07-1 | |||
Metam sodium [methyldithiocarbamate] | - | 1 | [102] |
144-54-7 | |||
Methylmercaptan | - | 1 | [165] |
74-93-1 | |||
Monoethanolamine | - | 1 | [184] |
141-43-5 | |||
N-methylmorpholine | [*] | 1 | [339] |
109-02-4 | |||
Nickel sulphate | (*) | 5 | [246-343] |
[arrow right]anhydrous 7786-81-4 | |||
[arrow right]hexahydrate 10101-97-0 | |||
Ninhydrin 485-47-2 | - | 1 | [335] |
Nitrogen chloride [nitrogen trichloride, trichloramine] | [*] | 2 | [150-344] |
10025-85-1 | |||
Ozone (gassings) | * | 1 | [345] |
10028-15-6 | |||
Palladium | - | 1 | [346] |
7440-05-3 | |||
Paraphenylenediamine | (*) | 1 | [347] |
106-50-3 | |||
Paraquat | * | 2 | [128-151] |
4685-14-7 | |||
Persulfate | |||
", not specified | (*) | 2 | [348-349] |
", ammonium | - | 1 | [350] |
", potassium (7727-21-1) and ammonium peroxydisufate | [*] | 5 | [351] |
(7727-54-0) | |||
", alcalic | - | 1 | [352] |
", Sodium persulfate | - | 1 | [353] |
7775-27-1 | |||
", Dipotassium peroxo-peroxodisulfate [potassium persulfate] 7727-21-1 | - | 1 | [354] |
", Diammonium peroxodisulfate [ammonium persulfate] | * | 4 | [355-357] |
7727-54-0 | |||
Phenylglycine acid chloride | * | 1 | [358] |
39478-47-2 | |||
Phosgene | - | 2 | [35-359] |
75-44-5 | |||
Piperazine dihydrochloride | * | 3 | [130-274] |
142-64-3 | |||
Platinum salts | ** | 8 | [131-365] |
(7440-06-4) | |||
Polyethylene | - | 3 | [366-368] |
9002-88-4 | |||
Polymethyl-methacrylate [plexiglas powder] | - | 1 | [369] |
9011-14-7 | |||
Polypropylene , heated to 250 °C | [*] | 2 | [370-371] |
9003-07-0 | |||
Polyvinyl chloride (fume) | * | 8 | [53-376] [377-378] |
9002-86-2 | |||
Potassium dichromate | (*) | 1 | [379] |
7778-50-9 ( see also chromium;cement) | |||
Potassium aluminum tetrafluoride | (*) | 1 | [380] |
14484-69-6 | |||
Rosin core solder , thermal decomposition [colophony] | * | 6 | [74-383] |
8050-09-7 | |||
Sodium azide (powder dust) | - | 1 | [384] |
26628-22-8 | |||
Sodium iso-nonanoyl oxybenzene sulphonate [SINOS] 123354-92-7 | (*) | 3 | [385-387] |
Sodium metabisulfite [metabisulfite sodium] | (*) | 6 | [103-392] |
7681-57-4 | |||
Styrene monomer | (*) | 3 | [132-394] |
100-42-5 | |||
Sulfur dioxide | *[*] | 5 | [35-397] |
7446-09-5 | |||
Sulfathiazole | - | 1 | [398] |
72-14-0 | |||
Terpene (3-carene) | - | 2 | [399-400] |
13466-78-9 | |||
Tetrachloroisophthalonitrile (fungicide) | - | 1 | [401] |
Tetrahydrothiophene | - | 1 | [402] |
110-01-0 | |||
Tetramethrin [1-(5-tretrazoly)- 4-guanyl-tetrazene hydrate] 7696-12-0 | - | 2 | [338-403] |
Tributyl tin oxide [carpet fungicide] | - | 1 | [404] |
Triethanolamine | - | 1 | [175] |
102-71-6 | |||
Tungsten carbide | - | 1 | [405] |
11130-73-7 | |||
Tylosin tartrate | - | 1 | [406] |
Uranium hexafluoride | - | 2 | [30-407] |
7783-81-5 | |||
Urea (fume) | - | 1 | [104] |
57-13-6 | |||
Urea formaldehyde foam | - | 1 | [408] |
64869-57-4/ | |||
Phenol-formaldehyde resin | |||
9003-35-4 | |||
Vanadium 7440-62-2 + divanadium pentoxide | * | 5 | [84-412] |
1314-62-1 | |||
Zinc (fume) | - | 3 | [413-415] |
7440-66-6 | |||
Zinc chloride (fume) | - | 1 | [183] |
7646-85-7 | |||
Mixed agent | Evidence level | Number of studies per agent | |
Acid fluxes | - | 1 | [74] |
Acrylic acid | - | 1 | [166] |
Airbag content | - | 1 | [416] |
Bleaching agent (fumes) | - | 1 | [99] |
Cement | ** | 14 | [111-427] |
65997-15-1 | |||
Chlorofluorocarbons | (*) | 2 | [428-429] |
(degradation products) | |||
Cleaning agents (not specified) | *[*] | 9 | [15-433] |
", detergents | - | 2 | [434-435] |
Coffee, green | * | 5 | [436-440] |
Cotton (dust, raw) | *[*] | (12) | [48-447] |
CNT 750 | |||
Cutting oil | - | 2 | [37-448] |
Diesel exhaust | * | 5 | [10-106] |
ECG ink | - | 2 | [449-450] |
Endotoxin (see also cotton dust, swine confinement, poultry confinement, house dust) | * | 2 | [41-451] |
Environmental tobacco smoke | ** | 10 | [117-453] |
Floor sealant (aromatic hydrocarbons) | - | 1 | [30] |
Fumigating agent | - | 1 | [30] |
Furan-based binder | - | 1 | [454] |
Grain | ** | 9 | [48-459] |
", rice | [*] | 1 | [460] |
Hairdressing chemicals | (*) | 1 | [281] |
Lubricants (not specified) | (*) | 2 | [10-57] |
Metal coat remover (coating removing chemical) | - | 1 | [30] |
Metal oxide (fume) | - | 1 | [461] |
Metal working fluids [MWF] | - | 1 | [462] |
Oil (spill) | * | 1 | [126] |
Paint (fumes) | * | 4 | [35-464] |
Paper dust A111 | (*) | 1 | [48] |
Perfume agents (research lab) | - | 1 | [37-465] |
Pesticides (not specified) | *[*] | 5 | [129-467] |
Polyamines , aliphatic | [*] | 1 | [468] |
Polyester | (*) | 2 | [469-470] |
Potroom aluminum smelting | *[*] | 10 | [52-478] |
Powder paints | (*) | 1 | [479] |
Pyrazolone (see reactive dye) | - | 1 | [480] |
Reactive dyes | * | 5 | [481-485] |
Refractory ceramic fibers [RCF] | * | 2 | [486-487] |
Smoke (fires, pyrolysis products) | *[*] | 5 | [30-490] |
", (oil fire and dust storm) | * | 1 | [491] |
", (biomass, indoor) | (*) | 1 | [492] |
Soldering flux (fumes) | * | 4 | [183-495] |
Solvents (not specified) | * | 4 | [10-497] |
Spray paint | - | 1 | [30] |
Tall oil | - | 1 | [498] |
Tear gas | - | 4 | [499-502] |
Welding fumes | ** | 18 | [41-513] |
Work-site or profession | Evidence level | Number of studies per work-site or profession | |
Ceramic production | *[*] | 2 | [514-515] |
Cleaners | |||
Construction work (dust, agent not specified) | ** | 5 | [8-517] |
Farming | |||
", (various) | *[*] | 9 | [119-521] |
", animals (pig, beef/veal, dairy, poultry) | ** | 3 | [522-524] |
Foundry | *[*] | 4 | [121-526] |
[see also isocyanates (MDI)] | |||
Health care workers | *[*] | 4 | [23-529] |
Metallurgical industry workers | * | 1 | [530] |
Poultry confinement | *(*) | 4 | [153-533] |
Poultry confinement, slaughtery house | * | 3 | [534-536] |
Swine confinement | ** | 8 | [39-540] |
World Trade Center disaster 2001 | ** | 8 | [133-546] |
[ ] down-grading due to lower quality of clinical investigations relative to the scale of the scientific level of the study.
(*) up-grading due to at least 5 cases without contradictory findings.
Table 4
Strength of evidence for agents, professions and work-site according to the modified RCGP three-star system [88]
Evidence level (modified RCGP three-star grading) | Number of agents/work-sites or professions | Agents, work-site or profession [Synonym] (CAS) |
*** | 0 | - |
** | 17 | Benzene-1, 2, 4-tricarboxylic acid-1,2-anhydride [trimellitic anhydride] (552-30-7); chlorine ( 7782-50-5); cobalt (7440-48-4); various isocyanates, isocyanurate (HDI, MDI, TDI), diphenylmethane diisocyanate [MDI] (5873-54-1), toluene diisocyanate, TDI 2,4 (584-84-9), TDI 2,6: (91-08-7); platinum salts (7440-06-4); cement ; environmental tobacco smoke; grain ; welding fumes; construction work (dust, agent not specified); farming, animals (pig, beef/veal, dairy, poultry); swine confinement; World Trade Center disaster 2001 |
*[*] | 12 | Ceramic production; Phthalic anhydride (85-44-9); glutaraldehyde [glutaral] (11-30-8); sulfur dioxide (7446-09-5); cotton (dust, raw) CNT 750; potroom aluminum smelting; farming (various); foundry; smoke (fires, pyrolysis products); pesticides (not specified); cleaning agents (not specified); health care workers |
* | 39 | Acetic acid (64-19-7); sulfuric acid (7664-93-9); metacrylates, loctide® (53858-53-0); aluminum salts [aluminum fluoride] (7724-18-1); aluminum sulfate: (10043-01-3); ammonia (7664-41-7); various anhydrides; tetrachlorophthalic anhydride (117-08-8); azobisformamide (123-77-3); cadmium (fumes) (7440-43-9); carbon black dust (1333-86-4); ethylenediamine (107-15-3); formaldehyde (gas, dust) (50-00-0); hexamethylenetetramine ( 100-97-0); methyl isocyanate [MIC] (624-83-9); naphthylene diisocyanate (3173-72-6); polymethylene polyphenyl isocyanate (9016-87-9); N-methylmorpholine (09-02-4); ozone (gassings) (10028-15-6); paraquat (4685-14-7); diammonium peroxodisulfate (7727-54-0); phenylglycine acid chloride ( 39478-47-2); piperazine dihydrochloride (142-64-3); polyvinyl chloride (fume) (9002-86-2); rosin core solder; thermal decomposition (8050-09-7); vanadium (7440-62-2) + divanadium pentoxide (1314-62-1); cleaning agents (not specified); green coffee ; diesel exhaust; endotoxin; oil (spill); paint (fumes); pesticides (not specified); reactive dyes; refractory ceramic fibers [RCF]; smoke (fires, pyrolysis products; oil fire and dust storm); soldering flux; solvents (not specified); health care workers; poultry confinement; slaughtery house; metallurgical industry workers |
[*] | 3 | Nitrogen chloride ( 10025-85-1); polyamines, aliphatic; potassium persulfate (7727-21-1) and ammonium peroxydisufate (7727-54-0); grain rice |
(*) | 29 | Acids not specified; hydrochloric acids (7647-01-0); alkyl cyanoacrylates; 3-amino-5-mercapto-1,2,4-triazole l(16691-43-3); aziridine, polyfunctional (64265-57-2); chloramine T (powder dust) (7080-50-4); chromate (not specified); 3-(diamino-amino)propylamine (109-55-7); dichlorodiethyl sulfide (505-60-2); 2-diethylaminoethanol (100-37-8); diinitrogen tetraoxide (10544-72-6); hexamethylene diisocyanate [HDI], plus isodurane diisocyanate (822-06-0); HDI biuret plus (4035-89-6); nickel sulphate anhydrous (7786-81-4); hexahydrate (10101-97-0); paraphenylenediamine (106-50-3); persulfate (not specified); polypropylene, heated to 250 °C (9003-07-0); potassium dichromate (7778-50-9); potassium aluminum tetrafluoride (14484-69-6); sodium iso-nonanoyl oxybenzene sulphonate [SINOS] (123354-92-7); sodium metabisulfite (7681-57-4); styrene monomer (100-42-5); chlorofluorocarbons (degradation products); hairdressing chemicals; lubricants (not specified); paper dust A111; aliphatic polyamines; polyester; powder paints; smoke (biomass, indoor) |
- | 93 | Acids various; dodecanedioic (693-23-2-1); hydrofluoric acids (7664-39-3); cyanoacrylate glue; methyl 2-cyanoacrylate (137-05-3); methylmethacrylate (80-62-6); 2-aminoethanol (141-43-5); amino-ethyl-ethanolamine (111-41-1); ammonium chloride (triple salt) (12125-02-9); ammonium thioglycolate (5421-46-5); amprolium hydrochloride (137-88-2); dioctyl phthalate (117-81-7); hexahydrophthalic anhydrides (37226-48-5); himic anhydrides (2746-19-2); maleic anhydrides (108-31-6); methyltetrahydrophthalic anhydrides (26590-20-9); pyromellitic dianhydride (89-32-7); benzalkonium chloride (fumes) (8001-54-5); 1, 2-benzisothiazoline-3-one (fumes) (2634-33-5); bisulfite, SO2 :(7446-09-5); hydrobromic acid bromine; bromochlorodifluoromethane [halon 1211] (353-59-3); bromotrifluoromethane [halon 1301](75-63-8); calcium carbonate [chalk powder]; calcium oxide (1305-78-8); captafol (2425-06-1); chlorhexidine (55-56-1); aliphatic + cycloaliphatic diamine, (hardener) (2855-13-2) [isophorone diamine]; diazonium tetrafluoroborate (14239-22-6); dichlorvos [organophosphate] (62-73-7); diethanolamine (111-42-2); 2-dimethylaminoethanol [dimethyl ethanolamine] (108-01-0); ethylene oxide (75-21-8); freon-22; hexachlorophene (70-30-4); hydrazine (302-01-2); iridium salt; isocyanate prepolymers; 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate (4098-71-9); triglycidil isocyanurate (2451-62-1); triphenylmethane triisocyanate; isothiazolinone (55965-84-9); lauryl dimethyl benzyl ammonium chloride (139-07-1); metam sodium (144-54-7); methylmercaptan (74-93-1); monoethanolamine (141-43-5); ninhydrin (485-47-2); palladium (7440-05-3); ammonium persulfate; alcalic persulfate; sodium persulfate (7775-27-1); dipotassium peroxo-peroxodisulfate (7727-21-1); phosgene (75-44-5); polyethylene (9002-88-4); polymethyl-methacrylate (9011-14-7); sodium azide (powder dust) (26628-22-8); sulfathiazole (2-14-0); terpene (3-carene) (3466-78-9); tetrahydrothiophene (110-01-0); tetrachloroisophthalonitrile (fungicide); tetramethrin (7696-12-0); tributyl tin oxide; triethanolamine (102-71-6); tungsten carbide (11130-73-7); turpentine (8006-64-2); tylosin tartrate; uranium hexafluoride (7783-81-5); urea (fume) (57-13-6); urea formaldehyde foam (64869-57-4); phenol-formaldehyde resin (9003-35-4); zinc (fume) (7440-66-6); zinc chloride (fume) (7646-85-7); acid fluxes; acrylic acid; airbag content; bleaching agent (fumes); chlorofluorocarbons (degradation products); detergents; cutting oil; ECG ink; floor sealant (aromatic hydrocarbons); fumigating agent; furan-based binder; metal coating remover (coating removing chemical); metal oxide (fume); metal working fluids; perfume agents (research lab); pyrazolone; spray paint; tall oil; tear gas |
CAS = Chemical abstracts service.
RCGP = Royal College of General Practitioners.
The compiled assessment of the individual studies, along with their relevant clinical data and strength of evidence for irritant agents, professions or workplaces causing asthma or COPD, is presented as a summary list (see Additional file 3: Table S2E "Results" for the full information).
Discussion
The main objective of this study was to give a comprehensive and evidence-based overview of the literature on irritative agents, professions or work-sites causing irritant-induced work-related asthma and occupational COPD. To our knowledge this study is the first attempts to document these respiratory disorders, along with their causative irritant agents in an evidence-based manner.
The 474 publications retrieved (see Table 3 and Additional file 3: Table S2E of online supplement "Results") in this work mainly refer to individual agents (n = 131), but also to mixed exposure(s) or multicomponent work-sites or professions (n = 57) where heterogeneous exposure to irritating substances is common, e.g. swine confinement, "construction work" or "farming", giving 188 different causes of irritant-induced OA and/or occupational COPD in total.
Strength and limitations
This work covers a broad range of causative agents of irritant-induced occupational asthma or COPD. We included various study designs.
A strength of our work is that we not only assessed the quality of single investigations but the strength of the body of evidence for each irritant agent.
The paradigm of "evidenced-based medicine" has been criticized by leading scientists [547-550]. Bias in the selection of information may be a problem for generalization of findings in single studies [551-552]. In spite of these limitations, alternative approaches to evaluation of the literature have not been generally accepted. Evaluation of the evidence depends on the domain, which means the factors to be considered in assessing the extent to which the study results are reliable or valid.
Kunz et al. [553] stressed the approach of grading scientific studies on basis of additional qualified data, i.e. dose response relationships. This latter was seen in 30/474 individual studies in this current work. Other studies were based on evidence by OR >2 or < 0.5 for irritant-induced OA and occupational COPD which was applied as an approach in 40/474 individual studies (see Additional file 3: Table S2E of online supplement "Results").
There are numerous procedural methods for rating the strength of scientific evidence. The AHRQ emphasized in 2002: "systems for grading the strength of a body of evidence are much less uniform than those for rating study quality" [554].
It is possible that not all relevant studies were found in our search of literature. Probably, some studies could not be found by the MeSH term raster applied. Relying solely on MeSH terms might be a problem in the identification of studies of irritant-induced OA or occupational COPD. We restricted the search to the MeSH fields in order to increase the specificity of the search. As for any electronic search strategy, an increase of specificity implies a decrease in sensitivity of the search.
For each single study, we took into consideration possible risks due to confounding, e.g. exposure to multiple agents and selection bias, e.g. healthy worker effect.
Basis and quality of data
Irritant-induced obstructive airways diseases cannot usually be diagnosed in one clinical visit and, instead, follow-up and/or detailed clinical investigations are necessary. The diagnostic "gold standard" for OA is SIC using a specific occupational agent in an exposure chamber. SIC is particularly indicated in the clinical setting where new causative substances with still unknown adverse respiratory sensitization potential are suspected. This "gold standard" is not applicable for large studies; so, it was used mainly in case series or reports.The evidence levels to confirm irritant-induced work-relaated asthma or occupational COPD for the listed irritant agents, professions or worksites (see Additional file 3: Table S2E of online supplement "Results") are frequently low with the major reasons being that high quality studies were missing and the quality of the available studies was low. Nevertheless, this knowledge is the best available and may help physicians to identify a suspected irritant agent as causative in irritant-induced work-related asthma and / or occupational COPD [555]. As also recently stressed by Quint et al. [555], "implementing an evidence-based identification and regulatory process for OA will help to ensure primary prevention of OA". In cases of low evidence level of an agent that does not exclude a causative role, caution should be exercised and a more detailed diagnostic testing of relevant exposure should be performed.
Occupational COPD, an underestimated category
We identified only 20 out of 474 publications that referred to occupational COPD, with most of them implicating inorganic or organic dust or fumes, such as cement dust, construction work and diesel exhaust, as the causative agents.
As an example, the mixed agent cement dust was investigated in 14 studies but only four studies documented cement dust as the causative agent in occupational COPD [111-422] (see Table 3 and Additional file 3: Table S2E "Results"). The remaining 10 studies described irritant-induced OA cases [235-530] or identified significant asthma symptoms/ obstructive ventilation patterns without a clear diagnosis (5 studies: [178-556]). It can be assumed that if it had been considered on the other 10 studies then occupational COPD caused by cement dust would have been frequently observed.
The population-attributable fraction for COPD associated with occupational exposure has been estimated between 9% and 31% [1-65]. However the true population-attributable risk due to occupational exposure is unclear [6-557] as occupational COPD is rarely clinically diagnosed. Blanc et al. [558] recently published an ecological analysis using data from three large studies, comprising the Burden of Obstructive Lung Disease study [169], the Latin American Project for Investigation of Obstructive Lung Disease (PLATINO) and the European Community Respiratory Health Survey follow-up (ECHRS II), where occupational COPD was also not a primary goal. The original publications are mainly concerned with OA or asthma symptoms, but a history of pre-existing OA or RADS cannot be allowed to exclude occupational COPD [559]. Blanc et al. [558] stressed that the contribution of occupational exposure cannot be ignored, because "the association between adverse working conditions and COPD (...) carries significance as a global finding (...), alongside the (...) critical contribution of cigarette smoking to disease prevalence".
General acceptance of this statement does not exist [66-559], although evidence for an association between individual exposure levels and COPD is accumulating in the latest literature [1-561].
Irritant-induced WRA - a broader definition
Irritant-induced OA includes three subcategories that predominantly differ according to the concentration of irritants in the workplace atmosphere. It can occur without a latency period, such as RADS, as was shown for 46 causative agents in our study, with the highest prevalence after spills of acids or tear gas (see Additional file 3: Table S2E of online supplement"Results"). Other agents, e.g. isocyanates or welding fumes, usually induce a slower onset of low dose irritant-induced asthma with a latency period and mostly without evidence of an IgE-mediated pathomechanism.
The ACCP also stated in its last Consensus Statement in 2008 [24] that cases who do not meet the stringent criteria of RADS [30] (e.g. where there is a lag of several days before the onset of symptoms or where there is no single massive exposure but rather repeated exposure over days and weeks) should be subsumed into a broader category of irritant-induced OA. As outlined in the section "Introduction" Brooks et al. [31] and later also others, e.g. Burge [27] suggested using the term "not so sudden onset of irritant-induced asthma" for those developing the disorder after such exposure within a period of 2 days to 4 months. In an extended definition corresponding to ours, Burge [27] he used the term "low dose irritant-induced OA" for those developing the disorder after relatively low repeated exposure for more than 4 months.
Bardana [562] and Vandenplas and Malo [563] questioned whether such rather low concentrations could actually cause irritant-induced OA. These different opinions about the pathogenetic role of chronic or recurrent exposure(s) to low concentrations of respiratory irritants seem to be due to inadequate considering of the increased susceptibility of a small group of workers. Occupational disease statistics do mostly neither contain such cases nor work-aggravated asthma cases so far.
Another critical issue is the frequent disregarding of work-aggravated asthma due to occupational agents by physicians.
Comparison to occupational guidelines or consensus statements - what is new?
In the current analysis, the focus has been on irritant agents causing irritant-induced occupational asthma and COPD. Both entities have been underestimated or even overlooked in the past. Occupational COPD has not been considered as a subgroup of COPD thus so far [559-564]; and the definition of irritant-induced OA has been heterogenous at best [24-566]. Furthermore, the guidelines dealing with respiratory disorders have not even considered causation by individual irritant agents, so far.
The ACCP published a Consensus Statement in 2008 [24] which focuses on the diagnosis and management of WRA after a latency period, i.e. due allergens and "sensitizers" with unknown pathomechanisms, effectively sidelining irritant-induced OA to RADS.
The Agency for Healthcare Research and Quality (AHRQ) in its the Evidence Report "Diagnosis and Management of WRA" [552] addressed the key question of the best diagnostic approach for a patient with suspected WRA. In respect of irritant-induced OA, they only considered RADS as a non-allergic asthma due to mainly low molecular weight compounds of unknown pathomechanism.
The Canadian Thoracic Society "Guidelines for OA" [567] was the first evidence-based guideline, although irritant-induced OA was limited to RADS. If criteria were not fulfilled then irritant-induced OA was discussed as a controversial diagnosis. The three evidence levels in the "Guidelines for OA" were based on quality of scientific evidence within analyzed studies [568]. Compared with the modified RCGP three-star grading (see Additional file 2: Table S2D in online supplement "Methodology"), the different levels are defined in a more general way, i.e. not considering the quantitative aspect if only studies with lower scientific evidence exist.
The evidence review and recommendations for OA by the BOHRF [3-569] were designed to improve the prevention, identification and management of OA. This work mainly deals with asthma after a latency period and considers irritant-induced OA and RADS to be closely related entities. The difference in comparison with our analysis is obvious even though our evidence-based approach was closely related to the BOHRF guidelines and used the same grading systems.
In summary, the existing guidelines or statements mostly define irritant-induced OA as RADS. Work-aggravated asthma, and occupational COPD as a distinct entity, have not been considered in any guideline, although the latter is becoming recognized as such in more recent publications [557-564].
This evidence-based approach is the first which focuses on especially irritative agents within the broader definition of irritant-induced OA and occupational COPD. For clarification, the grading systems were modified in accordance with BOHRF [3] when considering the extent and quality of the clinical investigations, with the goal of creating evidence levels for causative irritative agents as precisely as possible.
Concluding remarks
OA is the most common chronic occupational lung disease in many industrialized countries [3]. COPD is the fourth leading cause of death worldwide with a significant portion of occupational cases [66]. The term occupational COPD does not officially exist. However, it has to be considered as a subcategory of COPD [559].
Our study shows that reliable, sensitive and specific methods are required in the diagnostic approach for confirming irritant-induced OA, work-aggravated asthma, or occupational COPD. The specific diagnostic work-up in a subject with such a suspected disorder depends on the individual clinical data and on the knowledge of asthma- or COPD-inducing agents in the workplace. On this basis, our review may help in diagnostics especially for agent exposures where we were able to relate irritant-induced work-related asthma or occupational COPD to a high evidence-based level (i.e. two stars according to the RCGP grading).
We have created a list representing the strength of evidence for irritating agents to be causative in irritant-induced work-related asthma or occupational COPD (see Additional file 3: Table S2E of online supplement "Results").
A low level or absence of evidence for many agents in causing irritant-induced work-related asthma or occupational COPD is sometimes due to contradictory findings in literature, but is mostly due to the absence of rigorous scientific studies, with many gaps remaining in the knowledge of a causative role for individual agents and conditions. Therefore, and because of rarely applied diagnostic approach in the clinical setting, our literature search and evaluation lead us to assume that irritant-induced respiratory disorders are considerably underreported in cross-sectional studies and occupational disease statistics.
Our list needs updating in the light of recent literature, in order to provide a realistic overview of agents and evidence level in their causation of irritant-induced work-related or occupational COPD.
The estimated high population-attributable risk in the range of 5-25% for occupational asthma and COPD from occupational exposure, indicates that more detailed and intensive research, as well as strategies designed to prevent these disorders, should receive high priority in the global efforts to reduce the burden of these diseases. This implies extended evidence-based diagnostic procedures that help to optimize primary and secondary prevention by the physicians dealing with occupational diseases.
Reduction of the exposure to noxious agents by lowering the permissible exposure limits is the best and favoured way for intervention. If this is not possible then other effective primary preventive measures, such as wearing adequate respiratory devices, are required [28-574].
Finally, we would like to mention that the diagnosis of irritant-induced OA should be considered if:
there has been exposure to high concentration of an irritative agent identified in this study and the development of asthma without a latency period (original definition of RADS) or
there has been chronic or repeated exposures to moderate (in the TLV ranges) concentrations of an irritative agent identified in this review and the development of asthma with a latency period, but without evidence of an IgE-mediated pathomechanism and
there is evidence that a highly susceptible subject (e.g. with pre-existing NSBHR) develops new onset asthma upon occupational exposure to an identified irritative agent even at concentrations below the TLV.
Work-aggravated asthma should be considered if:
there have been any of the before-mentioned exposures and
there is a temporally related significant worsening of a pre-existing asthma or of a concomitant non-occupational asthma.
The diagnosis of occupational COPD should be considered if:
there has been exposure to an agent capable of causing occupational COPD, and
not reversible chronic airway disease is demonstrated and
there is a temporal relationship between the period of exposure (mostly cumulative exposures to identified irritants ) and the development of COPD (acute WRA symptoms are frequently missing).
Occupational COPD has to be taken into consideration especially in non-smokers, i.e. when dominating non-occupational causes for COPD are obviously not present.
Endnotes
a Epidemiologic study design which is generally applied to test one or more specific hypotheses, typically whether an exposure is a risk factor for a disease [575].
Abbreviations
CAS: Chemical abstracts service; COPD: Chronic obstructive pulmonary disease; OA: Occupational asthma; RADS: Reactive airways dysfunction syndrome; RCGP: Royal college of general practitioners; SIGN: Scottish intercollegiate guideline network; WRA: Work-related asthma.
Competing interests
The authors declare that they have no conflict of interest.
Authors' contributions
All authors made substantial contributions to the study. XB made the design of the study and the final interpretation of data. HV and PB did the detailed literature search, data extraction and analyses, and statistical analyses. XB and HV wrote the manuscript with input from PB. All authors approved the final version for submission.
Acknowledgements
We thank Marcial Velasco Garrido for critical review and support in drafting the manuscript.
[1] Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz D, Toren K, Viegi G, American Thoracic Society Statement: Occupational contribution to the burden of airway diseaseIn Am J Respir Crit Care Med,2003,167: 5:787-797.
[2] Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DIIn Asthma in the workplace and related conditions Taylor & Francis, New York 3,2006
[3] Nicholson PJ, Cullinan P, Burge PS, Boyle CIn Occupational asthma: Prevention, identification & management: Systematic review & recommendations British Occupational Health Research Foundation, London,2010 Note: http://www.bohrf.org.uk/downloads/OccupationalAsthmaEvidenceReview-Mar2010.pdf
[4] Arif AA, Whitehead LW, Delclos GL, Tortolero SR, Lee ES, Prevalence and risk factors of work related asthma by industry among United States workers: data from the third national health and nutrition examination survey (1988-94)In Occup Environ Med,2002,59: 8:505-511.
[5] Bakke PS, Baste V, Hanoa R, Gulsvik A, Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agentsIn Thorax,1991,46: 12:863-870.
[6] Becklake MR, Occupational exposures: evidence for a causal association with chronic obstructive pulmonary diseaseIn Am Rev Respir Dis,1989,140: 3 Pt 2:S85-S91.
[7] Becklake MR, Malo J-L, Chan-Yeung MY, Epidemiological approaches in occupational asthmaIn Asthma in the workplace Edited by: Bernstein IL, Chan-Yeung M, Malo J-L, Bernstein DI Taylor & Francis Group, New York, London 3,200637-85.
[8] Bergdahl IA, Toren K, Eriksson K, Hedlund U, Nilsson T, Flodin R, Jarvholm B, Increased mortality in COPD among construction workers exposed to inorganic dustIn Eur Respir J,2004,23: 3:402-406.
[9] Blanc PD, Toren K, How much adult asthma can be attributed to occupational factors?In Am J Med,1999,107: 6:580-587.
[10] Henneberger PK, Derk SJ, Davis L, Tumpowsky C, Reilly MJ, Rosenman KD, Schill DP, Valiante D, Flattery J, Harrison R, Work-related reactive airways dysfunction syndrome cases from surveillance in selected US statesIn J Occup Environ Med,2003,45: 4:360-368.
[11] Karjalainen A, Kurppa K, Martikainen R, Klaukka T, Karjalainen J, Work is related to a substantial portion of adult-onset asthma incidence in the Finnish populationIn Am J Respir Crit Care Med,2001,164: 4:565-568.
[12] Kogevinas M, Anto JM, Sunyer J, Tobias A, Kromhout H, Burney P, Occupational asthma in Europe and other industrialised areas: a population-based study. European Community Respiratory Health Survey Study GroupIn Lancet,1999,353: 9166:1750-1754.
[13] Leuenberger P, Schindler C, Schwartz J, Ackermann-Liebrich U, Tara D, Perruchoud AP, Wuthrich B, Zellweger JP, Blaser K, Bolognini G, Occupational exposure to inhalative irritants and methacholine responsivenessIn Scand J Work Environ Health,2000,26: 2:146-152.
[14] Le Moual N, Kennedy SM, Kauffmann F, Occupational exposures and asthma in 14,000 adults from the general populationIn Am J Epidemiol,2004,160: 11:1108-1116.
[15] Medina-Ramon M, Zock JP, Kogevinas M, Sunyer J, Anto JM, Asthma symptoms in women employed in domestic cleaning: a community based studyIn Thorax,2003,58: 11:950-954.
[16] Meldrum M, Rawbone R, Curran AD, Fishwick D, The role of occupation in the development of chronic obstructive pulmonary disease (COPD)In Occup Environ Med,2005,62: 4:212-214.
[17] Taylor AJ, Respiratory irritants encountered at workIn Thorax,1996,51: 5:541-545.
[18] Petsonk EL, Work-related asthma and implications for the general publicIn Environ Health Perspect,2002,110: Suppl 4:569-572.
[19] Viegi G, Di Pede C, Chronic obstructive lung diseases and occupational exposureIn Curr Opin Allergy Clin Immunol,2002,2: 2:115-121.
[20] , Reducing Risks, Promoting Healthy LifeIn The World Health Report 2002 WHO, Geneva,2002
[21] Xu X, Christiani DC, Dockery DW, Wang L, Exposure-response relationships between occupational exposures and chronic respiratory illness: a community-based studyIn Am Rev Respir Dis,1992,146: 2:413-418.
[22] Toren K, Blanc PD, Asthma caused by occupational exposures is common - a systematic analysis of estimates of the population-attributable fractionIn BMC Pulm Med,2009,9:7
[23] Kogevinas M, Zock JP, Jarvis D, Kromhout H, Lillienberg L, Plana E, Radon K, Toren K, Alliksoo A, Benke G, Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II)In Lancet,2007,370: 9584:336-341.
[24] Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, Diagnosis and management of work-related asthma: American College of Chest Physicians Consensus StatementIn Chest,2008,134:1-41.
[25] Henneberger PK, Redlich CA, Callahan DB, Harber P, Lemiere C, Martin J, Tarlo SM, Vandenplas O, Toren K, An official american thoracic society statement: work-exacerbated asthmaIn Am J Respir Crit Care Med,2011,184: 3:368-378.
[26] Lemiere C, Forget A, Dufour MH, Boulet LP, Blais L, Characteristics and medical resource use of asthmatic subjects with and without work-related asthmaIn J Allergy Clin Immunol,2007,120: 6:1354-1359.
[27] Burge SP, Moore VC, Robertson AS, Sensitization and irritant-induced occupational asthma with latency are clinically indistinguishableIn Occup Med (Lond),2012,62: 2:129-133.
[28] Baur X, Sigsgaard T, Aasen TB, Burge PS, Heederik D, Henneberger P, Maestrelli P, Rooyackers J, Schlunssen V, Vandenplas O, Guidelines for the management of work-related asthmaIn Eur Respir J,2012,39: 3:529-545.
[29] Baur X, Aasen TB, Burge PS, Heederik D, Henneberger PK, Maestrelli P, Schlunssen V, Vandenplas O, Wilken D, The management of work-related asthma guidelines: a broader perspectiveIn Eur Respir Rev,2012,21: 124:125-139.
[30] Brooks SM, Weiss MA, Bernstein IL, Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposuresIn Chest,1985,88: 3:376-384.
[31] Brooks SM, Hammad Y, Richards I, Giovinco-Barbas J, Jenkins K, The spectrum of irritant-induced asthma: sudden and not-so-sudden onset and the role of allergyIn Chest,1998,113: 1:42-49.
[32] Chan-Yeung M, Lam S, Kennedy SM, Frew AJ, Persistent asthma after repeated exposure to high concentrations of gases in pulpmillsIn Am J Respir Crit Care Med,1994,149: 6:1676-1680.
[33] Humerfelt S, Gulsvik A, Skjaerven R, Nilssen S, Kvale G, Sulheim O, Ramm E, Eilertsen E, Humerfelt SB, Decline in FEV1 and airflow limitation related to occupational exposures in men of an urban communityIn Eur Respir J,1993,6: 8:1095-1103.
[34] Krzyzanowski M, Jedrychowski W, Wysocki M, Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow Study. Risk of chronic obstructive pulmonary diseaseIn Am Rev Respir Dis,1986,134: 5:1011-1019.
[35] Tarlo SM, Broder I, Irritant-induced occupational asthmaIn Chest,1989,96: 2:297-300.
[36] Gautrin D, Bernstein IL, Brooks SM, Henneberger PK, Reactive airways dysfunction syndrome and irritant-induced asthmaIn Asthma in the workplace Edited by: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI Taylor & Francis Group, New York, London,2006581-629.
[37] Kipen HM, Blume R, Hutt D, Asthma experience in an occupational and environmental medicine clinic. Low-dose reactive airways dysfunction syndromeIn J Occup Med,1994,36: 10:1133-1137.
[38] Dykewicz MS, Occupational asthma: current concepts in pathogenesis, diagnosis, and managementIn J Allergy Clin Immunol,2009,123: 3:519-528. Note: quiz 529-530
[39] Cormier Y, Coll B, Laviolette M, Boulet LP, Reactive airways dysfunction syndrome (RADS) following exposure to toxic gases of a swine confinement buildingIn Eur Respir J,1996,9: 5:1090-1091.
[40] Dosman JA, Lawson JA, Kirychuk SP, Cornier Y, Biem J, Koehncke N, Occupational asthma in newly employed workers in intensive swine confinement facilitiesIn Eur Respir J,2004,24:698-702.
[41] Reinisch F, Harrison RJ, Cussler S, Athanasoulis M, Balmes J, Blanc P, Cone J, Physician reports of work-related asthma in California, 1993-1996In Am J Ind Med,2001,39: 1:72-83.
[42] Liss GM, Tarlo SM, Doherty J, Purdham J, Greene J, McCaskell L, Kerr M, Physician diagnosed asthma, respiratory symptoms, and associations with workplace tasks among radiographers in Ontario, CanadaIn Occup Environ Med,2003,60: 4:254-261.
[43] Smedley J, Coggon D, Health surveillance for hospital employees exposed to respiratory sensitizersIn Occup Med (Lond),1996,46: 1:33-36.
[44] Toren K, Jarvholm B, Brisman J, Hagberg S, Hermansson BA, Lillienberg L, Adult-onset asthma and occupational exposuresIn Scand J Work Environ Health,1999,25: 5:430-435.
[45] Makker HK, Ayres JG, Work-related asthma in an aircraft engine mechanicIn Respir Med,1999,93: 1:69-70.
[46] Wade JF, Newman LS, Diesel asthma. Reactive airways disease following overexposure to locomotive exhaustIn J Occup Med,1993,35: 2:149-154.
[47] Baur X, Airborne allergens and irritants in the workplaceIn Allergy and allergic diseases Edited by: Kay AB, Kaplan AP, Bousquet J, Holt PG Blackwell Publishing, Boston,20081017-1122.
[48] Toren K, Balder B, Brisman J, Lindholm N, Lowhagen O, Palmqvist M, Tunsater A, The risk of asthma in relation to occupational exposures: a case-control study from a Swedish cityIn Eur Respir J,1999,13: 3:496-501.
[49] Hnizdo E, Sullivan PA, Bang KM, Wagner G, Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination SurveyIn Am J Epidemiol,2002,156: 8:738-746.
[50] Oxman AD, Muir DC, Shannon HS, Stock SR, Hnizdo E, Lange HJ, Occupational dust exposure and chronic obstructive pulmonary diseaseIn A systematic overview of the evidence. Am Rev Respir Dis,1993,148: 1:38-48.
[51] Marine WM, Gurr D, Jacobsen M, Clinically important respiratory effects of dust exposure and smoking in British coal minersIn Am Rev Respir Dis,1988,137: 1:106-112.
[52] Kongerud J, Gronnesby JK, Magnus P, Respiratory symptoms and lung function of aluminum potroom workersIn Scand J Work Environ Health,1990,16: 4:270-277.
[53] Andrasch RH, Bardana EJ, Koster F, Pirofsky B, Clinical and bronchial provocation studies in patients with meatwrappers' asthmaIn J Allergy Clin Immunol,1976,58: 2:291-298.
[54] Carlsen KH, Anderson SD, Bjermer L, Bonini S, Brusasco V, Canonica W, Cummiskey J, Delgado L, Del Giacco SR, Drobnic F, Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: Part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LENIn Allergy,2008,63:387-403.
[55] Karjalainen A, Kurppa K, Virtanen S, Keskinen H, Nordman H, Incidence of occupational asthma by occupation and industry in FinlandIn Am J Ind Med,2000,37: 5:451-458.
[56] Hansson SO, Critical effects and exposure limitsIn Risk Anal,1997,17: 2:227-236.
[57] Latza U, Baur X, Occupational obstructive airway diseases in Germany: Frequency and causes in an international comparisonIn Am J Ind Med,2005,48: 2:144-152.
[58] Chan-Yeung M, Malo JL, Aetiological agents in occupational asthmaIn Eur Respir J,1994,7: 2:346-371.
[59] Fernandez-Nieto M, Quirce S, Sastre J, Occupational asthma in industryIn Allergol Immunopathol (Madr),2006,34: 5:212-223.
[60] Baur X, Latza U, Non-malignant occupational respiratory diseases in Germany in comparison with those of other countriesIn Int Arch Occup Environ Health,2005,78: 7:593-602.
[61] Ameille J, Pauli G, Calastreng-Crinquand A, Vervloet D, Iwatsubo Y, Popin E, Bayeux-Dunglas MC, Kopferschmitt-Kubler MC, Reported incidence of occupational asthma in France, 1996-99: the ONAP programmeIn Occup Environ Med,2003,60: 2:136-141.
[62] Tarlo SM, Liss GM, Occupational asthma: an approach to diagnosis and managementIn CMAJ,2003,168: 7:867-871.
[63] Pesci A, Majori M, Cuomo A, Borciani N, Bertacco S, Cacciani G, Gabrielli M, Neutrophils infiltrating bronchial epithelium in chronic obstructive pulmonary diseaseIn Respir Med,1998,92: 6:863-870.
[64] Hnizdo E, Glindmeyer HW, Petsonk EL, Enright P, Buist AS, Case definitions for chronic obstructive pulmonary diseaseIn Copd,2006,3: 2:95-100.
[65] Trupin L, Earnest G, San Pedro M, Balmes JR, Eisner MD, Yelin E, Katz PP, Blanc PD, The occupational burden of chronic obstructive pulmonary diseaseIn Eur Respir J,2003,22: 3:462-469.
[66] Balmes JR, Occupational airways diseases from chronic low-level exposures to irritantsIn Clin Chest Med,2002,23: 4:727-735. Note: vi
[67] Hendrick DJ, Smoking, cadmium, and emphysemaIn Thorax,2004,59: 3:184-185.
[68] Davison AG, Fayers PM, Taylor AJ, Venables KM, Darbyshire J, Pickering CA, Chettle DR, Franklin D, Guthrie CJ, Scott MC, Cadmium fume inhalation and emphysemaIn Lancet,1988,1: 8587:663-667.
[69] , Standards for the diagnosis and care of patients with chronic obstructive pulmonary diseaseIn Am J Respir Crit Care Med,1995,152:77-121.
[70] Postma DS, Boezen HM, Rationale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPDIn Chest,2004,126: 2 Suppl:96S-104S. Note: discussion 159S-161S
[71] Balmes JR, Work-related COPDIn Eur Respir J,1994,7:768-778.
[72] Bourdin A, Serre I, Flamme H, Vic P, Neveu D, Aubas P, Godard P, Chanez P, Can endobronchial biopsy analysis be recommended to discriminate between asthma and COPD in routine practice?In Thorax,2004,59: 6:488-493.
[73] Hargreave FE, Parameswaran K, Asthma, COPD and bronchitis are just components of airway diseaseIn Eur Respir J,2006,28: 2:264-267.
[74] Gannon PF, Burge PS, The SHIELD scheme in the West Midlands Region, United Kingdom. Midland Thoracic Society Research GroupIn Br J Ind Med,1993,50: 9:791-796.
[75] Eisner MD, Yelin EH, Katz PP, Lactao G, Iribarren C, Blanc PD, Risk factors for work disability in severe adult asthmaIn Am J Med,2006,119: 10:884-891.
[76] Toren K, Brisman J, Olin AC, Blanc PD, Asthma on the job: work-related factors in new-onset asthma and in exacerbations of pre-existing asthmaIn Respir Med,2000,94: 6:529-535.
[77] Brändli O, Schindler C, Leuenberger PH, Baur X, Degens P, Kunzli N, Keller R, Perruchoud AP, Re-estimated equations for 5th percentiles of lung function variablesIn Thorax,2000,55: 2:173-174.
[78] , Regulation (EC) No 1272/2008 of the European Parliament and on the Council of 16 December 2008 on classification, labelling and packing of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulations (EC) No 1907/2006In Off J EU,2008,L 353:1-1355. Note: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:353:0001:0001:en:PDF
[79] In TLVs® and BEIs®. Threshold limit values for chemical substances and physical agents & biological exposure indices ACGIH, Cincinnaty,2009
[80] Baur X, Occupational agents with respiratory effects according to ACGIH 2009 and / or classified with the R42 phrase* (may cause sensitization by inhalation) and / or with the R37 phrase* (irritating to respiratory system) according to the European Union directives 67/548/EEC (1), 2001/59/EC (2), 2004/73/EC (3) or 2009/2/EC (4) (identical to ILO/CIS 2002In ,2009 Note: http://www.ilo.org/public/english/protection/safework/cis/products/icsc/dtasht/riskphrs/index.htm) http://www.uke.de/institute/arbeitsmedizin/downloads/universitaetsprofessur-arbeitsmedizin/R42_und_R37A-EU09.pdf and www.eomsociety.org => knowledge center
[81] Meyer JD, Holt DL, Chen Y, Cherry NM, McDonald JC, SWORD '99: surveillance of work-related and occupational respiratory disease in the UKIn Occup Med (Lond),2001,51: 3:204-208.
[82] Meyer JD, Holt DL, Cherry NM, McDonald JC, SWORD '98: surveillance of work-related and occupational respiratory disease in the UKIn Occup Med (Lond),1999,49: 8:485-489.
[83] Ross DJ, Keynes HL, McDonald JC, SWORD '96: surveillance of work-related and occupational respiratory disease in the UKIn Occup Med (Lond),1997,47: 6:377-381.
[84] Esterhuizen TM, Hnizdo E, Rees D, Occurrence and causes of occupational asthma in South Africa-results from SORDSA's Occupational Asthma Registry, 1997-1999In S Afr Med J,2001,91: 6:509-513.
[85] Buckley LA, Jiang XZ, James RA, Morgan KT, Barrow CS, Respiratory tract lesions induced by sensory irritants at the RD50 concentrationIn Toxicol Appl Pharmacol,1984,74: 3:417-429.
[86] Haupt B, Drechsel-Schlund C, Guldner K, Rogosky E, Plinske W, Butz MIn Dokumentation des Berufskrankheiten-Geschehens in Deutschland. BK-DOK 2005 Deutsche Gesetzliche Unfallversicherung (DGUV), Sankt Augustin,2007 Note: http://www.dguv.de/inhalt/zahlen/documents/bk_dok_2005.pdf
[87] Harbour R, Miller J, A new system for grading recommendations in evidence based guidelinesIn BMJ,2001,323: 7308:334-336.
[88] , The development and implementation of clinical guidelinesIn Report of the Clinical Guidelines Working Group RCGP, London,1995
[89] Alberts WM, do Pico GA, Reactive airways dysfunction syndromeIn Chest,1996,109: 6:1618-1626.
[90] , Guidelines for assessing and managing asthma risk at work, school, and recreationIn Am J Respir Crit Care Med,2004,169: 7:873-881.
[91] Baur X, Degens P, Weber K, Occupational obstructive airway diseases in GermanyIn Am J Ind Med,1998,33: 5:454-462.
[92] van Kampen V, Merget R, Baur X, Occupational airway sensitizers: an overview on the respective literatureIn Am J Ind Med,2000,38: 2:164-218.
[93] , Webpage Note: http://www.hse.gov.uk
[94] Malo JL, Irritant-induced asthma and reactive airways dysfunction syndromeIn Can Respir J,1998,5: 1:66-67.
[95] Malo JL, Chan-Yeung M, Asthma in the workplace: a Canadian contribution and perspectiveIn Can Respir J,2007,14: 7:407-413.
[96] McDonald JC, Keynes HL, Meredith SK, Reported incidence of occupational asthma in the United Kingdom, 1989-97In Occup Environ Med,2000,57: 12:823-829.
[97] Sastre J, Vandenplas O, Park HS, Pathogenesis of occupational asthmaIn Eur Respir J,2003,22: 2:364-373.
[98] Joules H, Asthma from sensitisation to chromiumIn Lancet,1932,2:182-183.
[99] Boulet LP, Increases in airway responsiveness following acute exposure to respiratory irritants. Reactive airway dysfunction syndrome or occupational asthma?In Chest,1988,94: 3:476-481.
[100] Simonsson BG, Sjoberg A, Rolf C, Haeger-Aronsen B, Acute and long-term airway hyperreactivity in aluminium-salt exposed workers with nocturnal asthmaIn Eur J Respir Dis,1985,66: 2:105-118.
[101] Matrat M, Laurence MF, Iwatsubo Y, Hubert C, Joly N, Legrand-Cattan K, L'Huillier JP, Villemain C, Pairon JC, Reactive airways dysfunction syndrome caused by bromochlorodifluoromethane from fire extinguishersIn Occup Environ Med,2004,61: 8:712-714.
[102] Cone JE, Wugofski L, Balmes JR, Das R, Bowler R, Alexeeff G, Shusterman D, Persistent respiratory health effects after a metam sodium pesticide spillIn Chest,1994,106: 2:500-508.
[103] Valero AL, Bescos M, Amat P, Malet A, Bronchial asthma caused by occupational sulfite exposureIn Allergol Immunopathol (Madr),1993,21: 6:221-224.
[104] Cockcroft DW, Hoeppner VH, Dolovich J, Occupational asthma caused by cedar urea formaldehyde particle boardIn Chest,1982,82: 1:49-53.
[105] Hart JE, Laden F, Schenker MB, Garshick E, Chronic obstructive pulmonary disease mortality in diesel-exposed railroad workersIn Environ Health Perspect,2006,114: 7:1013-1017.
[106] Hart JE, Laden F, Eisen EA, Smith TJ, Garshick E, Chronic obstructive pulmonary disease mortality in railroad workersIn Occup Environ Med,2009,66: 4:221-226.
[107] Ulvestad B, Lund MB, Increased risk of chronic obstructive pulmonary disease among tunnel construction workersIn Tidsskr Nor Laegeforen,2003,123: 16:2292-2295.
[108] Kern DG, Outbreak of the reactive airways dysfunction syndrome after a spill of glacial acetic acidIn Am Rev Respir Dis,1991,144: 5:1058-1064.
[109] Gamble J, Jones W, Hancock J, Meckstroth RL, Epidemiological-environmental study of lead acid battery workers. III. Chronic effects of sulfuric acid on the respiratory system and teethIn Environ Res,1984,35: 1:30-52.
[110] Bohadana AB, Massin N, Wild P, Berthiot G, Airflow obstruction in chalkpowder and sugar workersIn Int Arch Occup Environ Health,1996,68: 4:243-248.
[111] Mwaiselage J, Bratveit M, Moen BE, Mashalla Y, Respiratory symptoms and chronic obstructive pulmonary disease among cement factory workersIn Scand J Work Environ Health,2005,31: 4:316-323.
[112] Massin N, Hecht G, Ambroise D, Hery M, Toamain JP, Hubert G, Dorotte M, Bianchi B, Respiratory symptoms and bronchial responsiveness among cleaning and disinfecting workers in the food industryIn Occup Environ Med,2007,64: 2:75-81.
[113] Sprince NL, Oliver LC, Eisen EA, Greene RE, Chamberlin RI, Cobalt exposure and lung disease in tungsten carbide production. A cross-sectional study of current workersIn Am Rev Respir Dis,1988,138: 5:1220-1226.
[114] Woldeyohannes M, Bergevin Y, Mgeni AY, Theriault G, Respiratory problems among cotton textile mill workers in EthiopiaIn Br J Ind Med,1991,48: 2:110-115.
[115] Rylander R, Bergstrom R, Bronchial reactivity among cotton workers in relation to dust and endotoxin exposureIn Ann Occup Hyg,1993,37: 1:57-63.
[116] Rylander R, Haglind P, Lundholm M, Endotoxin in cotton dust and respiratory function decrement among cotton workers in an experimental cardroomIn Am Rev Respir Dis,1985,131: 2:209-213.
[117] Chen R, Tunstall-Pedoe H, Tavendale R, Environmental tobacco smoke and lung function in employees who never smoked: the Scottish MONICA studyIn Occup Environ Med,2001,58: 9:563-568.
[118] Janson C, Chinn S, Jarvis D, Zock JP, Toren K, Burney P, Effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey: a cross-sectional studyIn Lancet,2001,358: 9299:2103-2109.
[119] Hoppin JA, Umbach DM, London SJ, Alavanja MC, Sandler DP, Diesel exhaust, solvents, and other occupational exposures as risk factors for wheeze among farmersIn Am J Respir Crit Care Med,2004,169: 12:1308-1313.
[120] Melenka LS, Hessel PA, Yoshida K, Enarson DA, Lung health in Alberta farmersIn Int J Tuberc Lung Dis,1999,3: 10:913-919.
[121] Ahman M, Alexandersson R, Ekholm U, Bergstrom B, Dahlqvist M, Ulfvarson U, Impeded lung function in moulders and coremakers handling furan resin sandIn Int Arch Occup Environ Health,1991,63: 3:175-180.
[122] Post W, Heederik D, Houba R, Decline in lung function related to exposure and selection processes among workers in the grain processing and animal feed industryIn Occup Environ Med,1998,55: 5:349-355.
[123] Schwartz DA, Thorne PS, Yagla SJ, Burmeister LF, Olenchock SA, Watt JL, Quinn TJ, The role of endotoxin in grain dust-induced lung diseaseIn Am J Respir Crit Care Med,1995,152: 2:603-608.
[124] Pahwa P, Senthilselvan A, McDuffie HH, Dosman JA, Longitudinal estimates of pulmonary function decline in grain workersIn Am J Respir Crit Care Med,1994,150: 3:656-662.
[125] Wisnewski AV, Liu Q, Liu J, Redlich CA, Glutathione protects human airway proteins and epithelial cells from isocyanatesIn Clin Exp Allergy,2005,35: 3:352-357.
[126] Zock JP, Rodriguez-Trigo G, Pozo-Rodriguez F, Barbera JA, Bouso L, Torralba Y, Anto JM, Gomez FP, Fuster C, Verea H, Prolonged respiratory symptoms in clean-up workers of the prestige oil spillIn Am J Respir Crit Care Med,2007,176: 6:610-616.
[127] Wieslander G, Norback D, Edling C, Airway symptoms among house painters in relation to exposure to volatile organic compounds (VOCS)-a longitudinal studyIn Ann Occup Hyg,1997,41: 2:155-166.
[128] Castro-Gutierrez N, McConnell R, Andersson K, Pacheco-Anton F, Hogstedt C, Respiratory symptoms, spirometry and chronic occupational paraquat exposureIn Scand J Work Environ Health,1997,23: 6:421-427.
[129] Jones SM, Burks AW, Spencer HJ, Lensing S, Roberson PK, Gandy J, Helm RM, Occupational asthma symptoms and respiratory function among aerial pesticide applicatorsIn Am J Ind Med,2003,43: 4:407-417.
[130] Hagmar L, Bellander T, Ranstam J, Skerfving S, Piperazine-induced airway symptoms: exposure-response relationships and selection in an occupational settingIn Am J Ind Med,1984,6: 5:347-357.
[131] Calverley AE, Rees D, Dowdeswell RJ, Linnett PJ, Kielkowski D, Platinum salt sensitivity in refinery workers: incidence and effects of smoking and exposureIn Occup Environ Med,1995,52: 10:661-666.
[132] Lorimer WV, Lilis R, Nicholson WJ, Anderson H, Fischbein A, Daum S, Rom W, Rice C, Selikoff IJ, Clinical studies of styrene workers: initial findingsIn Environ Health Perspect,1976,17:171-181.
[133] Prezant DJ, Weiden M, Banauch GI, McGuinness G, Rom WN, Aldrich TK, Kelly KJ, Cough and bronchial responsiveness in firefighters at the World Trade Center siteIn N Engl J Med,2002,347: 11:806-815.
[134] Jaakkola MS, Leino T, Tammilehto L, Ylostalo P, Kuosma E, Alanko K, Respiratory effects of exposure to methacrylates among dental assistantsIn Allergy,2007,62: 6:648-654.
[135] Medina-Ramon M, Zock JP, Kogevinas M, Sunyer J, Torralba Y, Borrell A, Burgos F, Anto JM, Asthma, chronic bronchitis, and exposure to irritant agents in occupational domestic cleaning: a nested case-control studyIn Occup Environ Med,2005,62: 9:598-606.
[136] Sauni R, Oksa P, Huikko S, Roto P, Uitti J, Increased risk of asthma among Finnish construction workersIn Occup Med (Lond),2003,53: 8:527-531.
[137] Jaakkola MS, Piipari R, Jaakkola N, Jaakkola JJ, Environmental tobacco smoke and adult-onset asthma: a population-based incident case-control studyIn Am J Public Health,2003,93: 12:2055-2060.
[138] Greer JR, Abbey DE, Burchette RJ, Asthma related to occupational and ambient air pollutants in nonsmokersIn J Occup Med,1993,35: 9:909-915.
[139] Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blanc PD, Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary diseaseIn Environ Health,2005,4: 1:7
[140] Fidan F, Cimrin AH, Ergor G, Sevinc C, Airway disease risk from environmental tobacco smoke among coffeehouse workers in TurkeyIn Tob Control,2004,13: 2:161-166.
[141] Radon K, Busching K, Heinrich J, Wichmann HE, Jorres RA, Magnussen H, Nowak D, Passive smoking exposure: a risk factor for chronic bronchitis and asthma in adults?In Chest,2002,122: 3:1086-1090.
[142] Blanc PD, Ellbjar S, Janson C, Norback D, Norrman E, Plaschke P, Toren K, Asthma-related work disability in Sweden. The impact of workplace exposuresIn Am J Respir Crit Care Med,1999,160: 6:2028-2033.
[143] Flodin U, Jonsson P, Ziegler J, Axelson O, An epidemiologic study of bronchial asthma and smokingIn Epidemiology,1995,6: 5:503-505.
[144] Eduard W, Douwes J, Omenaas E, Heederik D, Do farming exposures cause or prevent asthma? Results from a study of adult Norwegian farmersIn Thorax,2004,59: 5:381-386.
[145] Hoppin JA, Umbach DM, London SJ, Alavanja MC, Sandler DP, Animal production and wheeze in the Agricultural Health Study: interactions with atopy, asthma, and smokingIn Occup Environ Med,2003,60: 8:e3
[146] Melbostad E, Eduard W, Magnus P, Determinants of asthma in a farming populationIn Scand J Work Environ Health,1998,24: 4:262-269.
[147] Mastrangelo G, Tartari M, Fedeli U, Fadda E, Saia B, Ascertaining the risk of chronic obstructive pulmonary disease in relation to occupation using a case-control designIn Occup Med (Lond),2003,53: 3:165-172.
[148] Mastrangelo G, Paruzzolo P, Mapp C, Asthma due to isocyanates: a mail survey in a 1% sample of furniture workers in the Veneto region, ItalyIn Med Lav,1995,86: 6:503-510.
[149] Meredith SK, Bugler J, Clark RL, Isocyanate exposure and occupational asthma: a case-referent studyIn Occup Environ Med,2000,57: 12:830-836.
[150] Jacobs JH, Spaan S, van Rooy GB, Meliefste C, Zaat VA, Rooyackers JM, Heederik D, Exposure to trichloramine and respiratory symptoms in indoor swimming pool workersIn Eur Respir J,2007,29: 4:690-698.
[151] Schenker MB, Stoecklin M, Lee K, Lupercio R, Zeballos RJ, Enright P, Hennessy T, Beckett LA, Pulmonary function and exercise-associated changes with chronic low-level paraquat exposureIn Am J Respir Crit Care Med,2004,170: 7:773-779.
[152] Senthilselvan A, McDuffie HH, Dosman JA, Association of asthma with use of pesticides. Results of a cross-sectional survey of farmersIn Am Rev Respir Dis,1992,146: 4:884-887.
[153] Danuser B, Weber C, Kunzli N, Schindler C, Nowak D, Respiratory symptoms in Swiss farmers: an epidemiological study of risk factorsIn Am J Ind Med,2001,39: 4:410-418.
[154] Andersson E, Nilsson T, Persson B, Wingren G, Toren K, Mortality from asthma and cancer among sulfite mill workersIn Scand J Work Environ Health,1998,24: 1:12-17.
[155] Preller L, Heederik D, Boleij JS, Vogelzang PF, Tielen MJ, Lung function and chronic respiratory symptoms of pig farmers: focus on exposure to endotoxins and ammonia and use of disinfectantsIn Occup Environ Med,1995,52: 10:654-660.
[156] Wheeler K, McKelvey W, Thorpe L, Perrin M, Cone J, Kass D, Farfel M, Thomas P, Brackbill R, Asthma diagnosed after 11 September 2001 among rescue and recovery workers: findings from the World Trade Center Health RegistryIn Environ Health Perspect,2007,115: 11:1584-1590.
[157] Rajan KG, Davies BH, Reversible airways obstruction and interstitial pneumonitis due to acetic acidIn Br J Ind Med,1989,46: 1:67-68.
[158] Kivity S, Fireman E, Lerman Y, Late asthmatic response to inhaled glacial acetic acidIn Thorax,1994,49: 7:727-728.
[159] Moore VC, Manney S, Vellore AD, Burge PS, Occupational asthma to gel flux containing dodecanedioic acidIn Allergy,2009,64: 7:1099-1100.
[160] Musk AW, Peach S, Ryan G, Occupational asthma in a mineral analysis laboratoryIn Br J Ind Med,1988,45: 6:381-386.
[161] Deschamps D, Soler P, Rosenberg N, Baud F, Gervais P, Persistent asthma after inhalation of a mixture of sodium hypochlorite and hydrochloric acidIn Chest,1994,105: 6:1895-1896.
[162] Promisloff RA, Lenchner GS, Phan A, Cichelli AV, Reactive airway dysfunction syndrome in three police officers following a roadside chemical spillIn Chest,1990,98: 4:928-929.
[163] Franzblau A, Sahakian N, Asthma following household exposure to hydrofluoric acidIn Am J Ind Med,2003,44: 3:321-324.
[164] el-Sadik YM, Osman HA, el-Gazzar RM, Exposure to sulfuric acid in manufacture of storage batteriesIn J Occup Med,1972,14: 3:224-226.
[165] Chatkin JM, Tarlo SM, Liss G, Banks D, Broder I, The outcome of asthma related to workplace irritant exposures: a comparison of irritant-induced asthma and irritant aggravation of asthmaIn Chest,1999,116: 6:1780-1785.
[166] Savonius B, Keskinen H, Tuppurainen M, Kanerva L, Occupational respiratory disease caused by acrylatesIn Clin Exp Allergy,1993,23: 5:416-424.
[167] Yacoub MR, Lemiere C, Malo JL, Asthma caused by cyanoacrylate used in a leisure activityIn J Allergy Clin Immunol,2005,116: 2:462
[168] Nakazawa T, Occupational asthma due to alkyl cyanoacrylateIn J Occup Med,1990,32: 8:709-710.
[169] Lozewicz S, Davison AG, Hopkirk A, Burge PS, Boldy DA, Riordan JF, McGivern DV, Platts BW, Davies D, Newman Taylor AJ, Occupational asthma due to methyl methacrylate and cyanoacrylatesIn Thorax,1985,40: 11:836-839.
[170] Chan CC, Cheong TH, Lee HS, Wang YT, Poh SC, Case of occupational asthma due to glue containing cyanoacrylateIn Ann Acad Med Singapore,1994,23: 5:731-733.
[171] Quirce S, Baeza ML, Tornero P, Blasco A, Barranco R, Sastre J, Occupational asthma caused by exposure to cyanoacrylateIn Allergy,2001,56: 5:446-449.
[172] Kopp SK, McKay RT, Moller DR, Cassedy K, Brooks SM, Asthma and rhinitis due to ethylcyanoacrylate instant glueIn Ann Intern Med,1985,102: 5:613-615.
[173] Weytjens K, Cartier A, Lemiere C, Malo JL, Occupational asthma to diacrylateIn Allergy,1999,54: 3:289-290.
[174] Pickering CA, Bainbridge D, Birtwistle IH, Griffiths DL, Occupational asthma due to methyl methacrylate in an orthopaedic theatre sisterIn Br Med J (Clin Res Ed),1986,292: 6532:1362-1363.
[175] Savonius B, Keskinen H, Tuppurainen M, Kanerva L, Occupational asthma caused by ethanolaminesIn Allergy,1994,49: 10:877-881.
[176] Pepys J, Pickering CA, Asthma due to inhaled chemical fumes-amino-ethyl ethanolamine in aluminium soldering fluxIn Clin Allergy,1972,2: 2:197-204.
[177] Hnizdo E, Sylvain D, Lewis DM, Pechter E, Kreiss K, New-onset asthma associated with exposure to 3-amino-5-mercapto-1,2,4-triazoleIn J Occup Environ Med,2004,46: 12:1246-1252.
[178] Ali BA, Ahmed HO, Ballal SG, Albar AA, Pulmonary function of workers exposed to ammonia: a study in the Eastern Province of Saudi ArabiaIn Int J Occup Environ Health,2001,7: 1:19-22.
[179] Bernstein DIIn Guidelines for the diagnosis and evaluation of occupational immunologic lung disease Mosby Co, St. Louis,1989
[180] de la Hoz RE, Schlueter DP, Rom WN, Chronic lung disease secondary to ammonia inhalation injury: a report on three casesIn Am J Ind Med,1996,29: 2:209-214.
[181] Leduc D, Gris P, Lheureux P, Gevenois PA, De Vuyst P, Yernault JC, Acute and long term respiratory damage following inhalation of ammoniaIn Thorax,1992,47: 9:755-757.
[182] Flury KE, Dines DE, Rodarte JR, Rodgers R, Airway obstruction due to inhalation of ammoniaIn Mayo Clin Proc,1983,58: 6:389-393.
[183] Weir DC, Robertson AS, Jones S, Burge PS, Occupational asthma due to soft corrosive soldering fluxes containing zinc chloride and ammonium chlorideIn Thorax,1989,44: 3:220-223.
[184] Gelfand HH, Respiratory Allergy Due to Chemical Compounds Encountered in the Rubber, Lacquer, Shellac, and Beauty Culture IndustriesIn J Allergy Clin Immunol,1963,34:374-381.
[185] Greene SA, Freedman S, Asthma due to inhaled chemical agents-amprolium hydrochlorideIn Clin Allergy,1976,6: 2:105-108.
[186] Baur X, Czuppon AB, Rauluk I, Zimmermann FB, Schmitt B, Egen-Korthaus M, Tenkhoff N, Degens PO, A clinical and immunological study on 92 workers occupationally exposed to anhydridesIn Int Arch Occup Environ Health,1995,67: 6:395-403.
[187] Drexler H, Weber A, Letzel S, Kraus G, Schaller KH, Lenhert G, Detection and clinical relevance of a type I allergy with occupational exposure to hexahydrophthalic anhydride and methyltetrahydrophthalic anhydrideIn Int Arch Occup Environ Health,1994,65: 5:279-283.
[188] Cipolla C, Belisario A, Sassi C, Auletti G, Nobile M, Raffi GB, Occupational asthma caused by dioctyl-phthalate in a bottle cap production workerIn Med Lav,1999,90: 3:513-518.
[189] Chee CB, Lee HS, Cheong TH, Wang YT, Poh SC, Occupational asthma due to hexahydrophthalic anhydride: a case reportIn Br J Ind Med,1991,48: 9:643-645.
[190] Rosenman KD, Bernstein DI, O'Leary K, Gallagher JS, D'Souza L, Bernstein IL, Occupational asthma caused by himic anhydrideIn Scand J Work Environ Health,1987,13: 2:150-154.
[191] Lee HS, Wang YT, Cheong TH, Tan KT, Chee BE, Narendran K, Occupational asthma due to maleic anhydrideIn Br J Ind Med,1991,48: 4:283-285.
[192] Graneek BJ, Durham SR, Newman Taylor AJ, Late asthmatic reactions and changes in histamine responsiveness provoked by occupational agentsIn Bull Eur Physiopathol Respir,1987,23: 6:577-581.
[193] Nielsen J, Welinder H, Skerfving S, Allergic airway disease caused by methyl tetrahydrophthalic anhydride in epoxy resinIn Scand J Work Environ Health,1989,15: 2:154-155.
[194] Nielsen J, Welinder H, Schutz A, Skerfving S, Specific serum antibodies against phthalic anhydride in occupationally exposed subjectsIn J Allergy Clin Immunol,1988,82: 1:126-133.
[195] Wernfors M, Nielsen J, Schutz A, Skerfving S, Phthalic anhydride-induced occupational asthmaIn Int Arch Allergy Appl Immunol,1986,79: 1:77-82.
[196] Frans A, Pahulycz C, Transient syndrome of acute irritation of the bronchi induced by single and massive inhalation of phthalic anhydrideIn Rev Pneumol Clin,1993,49: 5:247-251.
[197] Fawcett IW, Taylor AJ, Pepys J, Asthma due to inhaled chemical agents-epoxy resin systems containing phthalic acid anhydride, trimellitic acid anhydride and triethylene tetramineIn Clin Allergy,1977,7: 1:1-14.
[198] Maccia CA, Bernstein IL, Emmett EA, Brooks SM, In vitro demonstration of specific IgE in phthalic anhydride hypersensitivityIn Am Rev Respir Dis,1976,113: 5:701-704.
[199] Meadway J, Asthma and atopy in workers with an epoxy adhesiveIn Br J Dis Chest,1980,74: 2:149-154.
[200] Venables KM, Topping MD, Howe W, Luczynska CM, Hawkins R, Taylor AJ, Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugateIn Br Med J (Clin Res Ed),1985,290: 6463:201-204.
[201] Venables KM, Topping MD, Nunn AJ, Howe W, Newman Taylor AJ, Immunologic and functional consequences of chemical (tetrachlorophthalic anhydride)-induced asthma after four years of avoidance of exposureIn J Allergy Clin Immunol,1987,80: 2:212-218.
[202] Howe W, Venables KM, Topping MD, Dally MB, Hawkins R, Law JS, Taylor AJ, Tetrachlorophthalic anhydride asthma: evidence for specific IgE antibodyIn J Allergy Clin Immunol,1983,71: 1 Pt 1:5-11.
[203] Schlueter DP, Banaszak EF, Fink JN, Barboriak J, Occupational asthma due to tetrachlorophthalic anhydrideIn J Occup Med,1978,20: 3:183-188.
[204] Grammer LC, Shaughnessy MA, Kenamore BD, Clinical and immunologic outcome of 42 individuals with trimellitic anhydride-induced immunologic lung disease after transfer to low exposureIn Allergy Asthma Proc,2000,21: 6:355-359.
[205] Grammer LC, Shaughnessy MA, Kenamore BD, Yarnold PR, A clinical and immunologic study to assess risk of TMA-induced lung disease as related to exposureIn J Occup Environ Med,1999,41: 12:1048-1051.
[206] Grammer L, Shaughnessy M, Kenamore B, Utility of antibody in identifying individuals who have or will develop anhydride-induced respiratory diseaseIn Chest,1998,114: 4:1199-1202.
[207] Zeiss CR, Patterson R, Pruzansky JJ, Miller MM, Rosenberg M, Levitz D, Trimellitic anhydride-induced airway syndromes: clinical and immunologic studiesIn J Allergy Clin Immunol,1977,60: 2:96-103.
[208] Kanerva L, Keskinen H, Autio P, Estlander T, Tuppurainen M, Jolanki R, Occupational respiratory and skin sensitization caused by polyfunctional aziridine hardenerIn Clin Exp Allergy,1995,25: 5:432-439.
[209] Leffler CT, Milton DK, Occupational asthma and contact dermatitis in a spray painter after introduction of an aziridine cross-linkerIn Environ Health Perspect,1999,107: 7:599-601.
[210] Slovak AJ, Occupational asthma caused by a plastics blowing agent, azodicarbonamideIn Thorax,1981,36: 12:906-909.
[211] Kim CW, Cho JH, Leem JH, Ryu JS, Lee HL, Hong YC, Occupational asthma due to azodicarbonamideIn Yonsei Med J,2004,45: 2:325-329.
[212] Normand JC, Grange F, Hernandez C, Ganay A, Davezies P, Bergeret A, Prost G, Occupational asthma after exposure to azodicarbonamide: report of four casesIn Br J Ind Med,1989,46: 1:60-62.
[213] Valentino M, Comai M, Occupational asthma caused by azodicarbonamide: clinical caseIn G Ital Med Lav,1985,7: 2-3:97-99.
[214] Malo JL, Pineau L, Cartier A, Occupational asthma due to azobisformamideIn Clin Allergy,1985,15: 3:261-264.
[215] Purohit A, Kopferschmitt-Kubler MC, Moreau C, Popin E, Blaumeiser M, Pauli G, Quaternary ammonium compounds and occupational asthmaIn Int Arch Occup Environ Health,2000,73: 6:423-427.
[216] Bernstein JA, Stauder T, Bernstein DI, Bernstein IL, A combined respiratory and cutaneous hypersensitivity syndrome induced by work exposure to quaternary aminesIn J Allergy Clin Immunol,1994,94: 2 Pt 1:257-259.
[217] Moscato G, Omodeo P, Dellabianca A, Colli MC, Pugliese F, Locatelli C, Scibilia J, Occupational asthma and rhinitis caused by 1,2-benzisothiazolin-3-one in a chemical workerIn Occup Med (Lond),1997,47: 4:249-251.
[218] Burns MJ, Linden CH, Another hot tub hazard. Toxicity secondary to bromine and hydrobromic acid exposureIn Chest,1997,111: 3:816-819.
[219] de la Hoz RE, Reactive airways dysfunction syndrome following exposure to a fluorocarbonIn Eur Respir J,1999,13: 5:1192-1194.
[220] Chan OY, Poh SC, Lee HS, Tan KT, Kwok SF, Respiratory function in cadmium battery workers-a follow-up studyIn Ann Acad Med Singapore,1988,17: 2:283-287.
[221] Leduc D, de Francquen P, Jacobovitz D, Vandeweyer R, Lauwerys R, De Vuyst P, Association of cadmium exposure with rapidly progressive emphysema in a smokerIn Thorax,1993,48: 5:570-571.
[222] De Silva PE, Donnan MB, Chronic cadmium poisoning in a pigment manufacturing plantIn Br J Ind Med,1981,38: 1:76-86.
[223] Royce S, Wald P, Sheppard D, Balmes J, Occupational asthma in a pesticides manufacturing workerIn Chest,1993,103: 1:295-296.
[224] Neghab M, Mohraz MH, Hassanzadeh J, Symptoms of respiratory disease and lung functional impairment associated with occupational inhalation exposure to carbon black dustIn J Occup Health,2011,53: 6:432-438.
[225] Bourne MS, Flindt ML, Walker JM, Asthma due to industrial use of chloramineIn BMJ,1979,2: 6181:10-12.
[226] Feinberg SM, Watrons RM, Atopy to simple chemical compounds-sulfonechloramidesIn J Allergy Clin Immunol,1945,16: 5:209-220.
[227] Kujala VM, Reijula KE, Ruotsalainen EM, Heikkinen K, Occupational asthma due to chloramine-T solutionIn Respir Med,1995,89: 10:693-695.
[228] Jouannique V, Pillière F, Pouillard D, Gervais P, Rousselin X, Efthymiou ML, Asthme professionel à la chloramine TIn A propos de deux observations Société De Médicine et d'Hygiène du Travail, Paris,1992654-657.
[229] Dijkman JH, Vooren PH, Kramps JA, Occupational asthma due to inhalation of chloramine-T. I. Clinical observations and inhalation-provocation studiesIn Int Arch Allergy Appl Immunol,1981,64: 4:422-427.
[230] Waclawski ER, McAlpine LG, Thomson NC, Occupational asthma in nurses caused by chlorhexidine and alcohol aerosolsIn Bmj,1989,298: 6678:929-930.
[231] Glindmeyer HW, Lefante JJ, Freyder LM, Friedman M, Weill H, Jones RN, Relationship of asthma to irritant gas exposures in pulp and paper millsIn Respir Med,2003,97: 5:541-548.
[232] Andersson E, Olin AC, Hagberg S, Nilsson R, Nilsson T, Toren K, Adult-onset asthma and wheeze among irritant-exposed bleachery workersIn Am J Ind Med,2003,43: 5:532-538.
[233] Gautrin D, Leroyer C, L'Archeveque J, Dufour JG, Girard D, Malo JL, Cross-sectional assessment of workers with repeated exposure to chlorine over a three year periodIn Eur Respir J,1995,8: 12:2046-2054.
[234] Bherer L, Cushman R, Courteau JP, Quevillon M, Cote G, Bourbeau J, L'Archeveque J, Cartier A, Malo JL, Survey of construction workers repeatedly exposed to chlorine over a three to six month period in a pulpmill: II. Follow up of affected workers by questionnaire, spirometry, and assessment of bronchial responsiveness 18 to 24 months after exposure endedIn Occup Environ Med,1994,51: 4:225-228.
[235] Leroyer C, Dewitte JD, Bassanets A, Boutoux M, Daniel C, Clavier J, Occupational asthma due to chromiumIn Respiration,1998,65: 5:403-405.
[236] Chester EH, Gillespie DG, Krause FD, The prevalence of chronic obstructive pulmonary disease in chlorine gas workersIn Am Rev Respir Dis,1969,99: 3:365-373.
[237] Ferris BG, Burgess WA, Worcester J, Prevalence of chronic respiratory disease in a pulp mill and a paper mill in the United StatesIn Br J Ind Med,1967,24: 1:26-37.
[238] Lemiere C, Malo JL, Boutet M, Reactive airways dysfunction syndrome due to chlorine: sequential bronchial biopsies and functional assessmentIn Eur Respir J,1997,10: 1:241-244.
[239] Schonhofer B, Voshaar T, Kohler D, Long-term lung sequelae following accidental chlorine gas exposureIn Respiration,1996,63: 3:155-159.
[240] Olaguibel JM, Basomba A, Occupational asthma induced by chromium saltsIn Allergol Immunopathol (Madr),1989,17: 3:133-136.
[241] Onizuka R, Tanabe K, Nakayama Y, Fukuchi T, Nakata K, Hiki T, A case of chrome asthma induced by exposure to the stone cutter dustIn Arerugi,2006,55: 12:1556-1561.
[242] Fernandez-Nieto M, Quirce S, Carnes J, Sastre J, Occupational asthma due to chromium and nickel saltsIn Int Arch Occup Environ Health,2006,79: 6:483-486.
[243] Sastre J, Fernandez-Nieto M, Maranon F, Fernandez-Caldas E, Pelta R, Quirce S, Allergenic cross-reactivity between nickel and chromium salts in electroplating-induced asthmaIn J Allergy Clin Immunol,2001,108: 4:650-651.
[244] Nagasaka Y, Nakano N, Tohda Y, Nakajima S, Persistent reactive airway dysfunction syndrome after exposure to chromate]In Nihon Kyobu Shikkan Gakkai Zasshi,1995,33: 7:759-764.
[245] Park HS, Yu HJ, Jung KS, Occupational asthma caused by chromiumIn Clin Exp Allergy,1994,24: 7:676-681.
[246] Novey HS, Habib M, Wells ID, Asthma and IgE antibodies induced by chromium and nickel saltsIn J Allergy Clin Immunol,1983,72: 4:407-412.
[247] Bernstein IL, Merget R, MetalsIn Asthma in the workplace Edited by: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI Taylor & Francis, New York 3,2006525-554.
[248] Linna A, Oksa P, Palmroos P, Roto P, Laippala P, Uitti J, Respiratory health of cobalt production workersIn Am J Ind Med,2003,44: 2:124-132.
[249] Kusaka Y, Iki M, Kumagai S, Goto S, Epidemiological study of hard metal asthmaIn Occup Environ Med,1996,53: 3:188-193.
[250] Kennedy SM, Chan-Yeung M, Marion S, Lea J, Teschke K, Maintenance of stellite and tungsten carbide saw tips: respiratory health and exposure-response evaluationsIn Occup Environ Med,1995,52: 3:185-191.
[251] Roto P, Asthma, symptoms of chronic bronchitis and ventilatory capacity among cobalt and zinc production workersIn Scand J Work Environ Health,1980,6: Suppl 1:1-49.
[252] Pisati G, Zedda S, Outcome of occupational asthma due to cobalt hypersensitivityIn Sci Total Environ,1994,150: 1-3:167-171.
[253] Shirakawa T, Kusaka Y, Fujimura N, Goto S, Kato M, Heki S, Morimoto K, Occupational asthma from cobalt sensitivity in workers exposed to hard metal dustIn Chest,1989,95: 1:29-37.
[254] Shirakawa T, Kusaka Y, Fujimura N, Goto S, Morimoto K, The existence of specific antibodies to cobalt in hard metal asthmaIn Clin Allergy,1988,18: 5:451-460.
[255] Shirakawa T, Kusaka Y, Fujimura N, Kato M, Heki S, Morimoto K, Hard metal asthma: cross immunological and respiratory reactivity between cobalt and nickel?In Thorax,1990,45: 4:267-271.
[256] Gheysens B, Auwerx J, Van den Eeckhout A, Demedts M, Cobalt-induced bronchial asthma in diamond polishersIn Chest,1985,88: 5:740-744.
[257] Baik JJ, Yoon YB, Park HS, Cobalt-induced occupational asthma associated with systemic illnessIn J Korean Med Sci,1995,10: 3:200-204.
[258] Wilk-Rivard E, Szeinuk J, Occupational asthma with paroxysmal atrial fibrillation in a diamond polisherIn Environ Health Perspect,2001,109: 12:1303-1306.
[259] Krakowiak A, Dudek W, Tarkowski M, Swiderska-Kielbik S, Niescierenko E, Palczynski C, Occupational asthma caused by cobalt chloride in a diamond polisher after cessation of occupational exposure: a case reportIn Int J Occup Med Environ Health,2005,18: 2:151-158.
[260] Sargent EV, Brubaker RE, Mitchell CA, Respiratory effects of occupational exposure to an epoxy resin systemIn Arch Environ Health,1976,31: 5:236-240.
[261] Aleva RM, Aalbers R, Koeter GH, De Monchy JG, Occupational asthma caused by a hardener containing an aliphatic and a cycloaliphatic diamineIn Am Rev Respir Dis,1992,145: 5:1217-1218.
[262] Luczynska CM, Hutchcroft BJ, Harrison MA, Dornan JD, Topping MD, Occupational asthma and specific IgE to a diazonium salt intermediate used in the polymer industryIn J Allergy Clin Immunol,1990,85: 6:1076-1082.
[263] Graham VA, Coe MJ, Davies RJ, Occupational asthma after exposure to a diazonium saltIn Thorax,1981,36: 12:950-951.
[264] Emad A, Rezaian GR, The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 casesIn Chest,1997,112: 3:734-738.
[265] Deschamps D, Questel F, Baud FJ, Gervais P, Dally S, Persistent asthma after acute inhalation of organophosphate insecticideIn Lancet,1994,344: 8938:1712
[266] Barthel E, Irritative and allergic effects of pesticide aerosols on the respiratory tract and problems of their evaluationIn Z Gesamte Hyg,1983,29: 11:678-681.
[267] Piipari R, Tuppurainen M, Tuomi T, Mantyla L, Henriks-Eckerman ML, Keskinen H, Nordman H, Diethanolamine-induced occupational asthma, a case reportIn Clin Exp Allergy,1998,28: 3:358-362.
[268] Gadon ME, Melius JM, McDonald GJ, Orgel D, New-onset asthma after exposure to the steam system additive 2-diethylaminoethanolIn A descriptive study. J Occup Med,1994,36: 6:623-626.
[269] Vallieres M, Cockcroft DW, Taylor DM, Dolovich J, Hargreave FE, Dimethyl ethanolamine-induced asthmaIn Am Rev Respir Dis,1977,115: 5:867-871.
[270] Cockcroft DW, Cotton DJ, Mink JT, Nonspecific bronchial hyperreactivity after exposure to Western Red CedarIn Am Rev Respir Dis,1979,119: 3:505-510.
[271] Conrad E, Lo W, de Boisblanc BP, Shellito JE, Reactive airways dysfunction syndrome after exposure to dinitrogen tetroxideIn South Med J,1998,91: 4:338-341.
[272] Aldrich FD, Stange AW, Geesaman RE, Smoking and ethylene diamine sensitization in an industrial populationIn J Occup Med,1987,29: 4:311-314.
[273] Casas X, Badorrey I, Monso E, Morera J, Occupational asthma due to amines]In Arch Bronconeumol,2002,38: 2:93-94.
[274] Hagmar L, Bellander T, Bergoo B, Simonsson BG, Piperazine-induced occupational asthmaIn J Occup Med,1982,24: 3:193-197.
[275] Lam S, Chan-Yeung M, Ethylenediamine-induced asthmaIn Am Rev Respir Dis,1980,121: 1:151-155.
[276] Deschamps D, Rosenberg N, Soler P, Maillard G, Fournier E, Salson D, Gervais P, Persistent asthma after accidental exposure to ethylene oxideIn Br J Ind Med,1992,49: 7:523-525.
[277] Dugue P, Faraut C, Figueredo M, Bettendorf A, Salvadori JM, Occupational asthma provoked by ethylene oxide in a nurseIn Presse Med,1991,20: 30:1455
[278] Nunn AJ, Craigen AA, Darbyshire JH, Venables KM, Newman Taylor AJ, Six year follow up of lung function in men occupationally exposed to formaldehydeIn Br J Ind Med,1990,47: 11:747-752.
[279] Nordman H, Keskinen H, Tuppurainen M, Formaldehyde asthma-rare or overlooked?In J Allergy Clin Immunol,1985,75: 1 Pt 1:91-99.
[280] Burge PS, Harries MG, Lam WK, O'Brien IM, Patchett PA, Occupational asthma due to formaldehydeIn Thorax,1985,40: 4:255-260.
[281] Piipari R, Keskinen H, Agents causing occupational asthma in Finland in 1986-2002: cow epithelium bypassed by moulds from moisture-damaged buildingsIn Clin Exp Allergy,2005,35: 12:1632-1637.
[282] Kim CW, Song JS, Ahn YS, Park SH, Park JW, Noh JH, Hong CS, Occupational asthma due to formaldehydeIn Yonsei Med J,2001,42: 4:440-445.
[283] Lemiere C, Desjardins A, Cloutier Y, Drolet D, Perrault G, Cartier A, Malo JL, Occupational asthma due to formaldehyde resin dust with and without reaction to formaldehyde gasIn Eur Respir J,1995,8: 5:861-865.
[284] Porter JA, Letter: Acute respiratory distress following formalin inhalationIn Lancet,1975,2: 7935:603-604.
[285] Hendrick DJ, Lane DJ, Formalin asthma in hospital staffIn BMJ,1975,1: 5958:607-608.
[286] Sjogren B, Gunnare S, Sandler H, Inhalation of decomposed chlorodifluoromethane (freon-22) and myocardial infarctionIn Scand J Work Environ Health,2002,28: 3:205-207.
[287] Malo JL, Gagnon G, Cartier A, Occupational asthma due to heated freonIn Thorax,1984,39: 8:628-629.
[288] Vyas A, Pickering CA, Oldham LA, Francis HC, Fletcher AM, Merrett T, Niven RM, Survey of symptoms, respiratory function, and immunology and their relation to glutaraldehyde and other occupational exposures among endoscopy nursing staffIn Occup Environ Med,2000,57: 11:752-759.
[289] Curran AD, Burge PS, Wiley K, Clinical and immunologic evaluation of workers exposed to glutaraldehydeIn Allergy,1996,51: 11:826-832.
[290] Gannon PF, Bright P, Campbell M, O'Hickey SP, Burge PS, Occupational asthma due to glutaraldehyde and formaldehyde in endoscopy and x ray departmentsIn Thorax,1995,50: 2:156-159.
[291] Jachuck SJ, Bound CL, Steel J, Blain PG, Occupational hazard in hospital staff exposed to 2 per cent glutaraldehyde in an endoscopy unitIn J Soc Occup Med,1989,39: 2:69-71.
[292] Ong TH, Tan KL, Lee HS, Eng P, A case report of occupational asthma due to gluteraldehyde exposureIn Ann Acad Med Singapore,2004,33: 2:275-278.
[293] Cullinan P, Hayes J, Cannon J, Madan I, Heap D, Taylor AN, Occupational asthma in radiographersIn Lancet,1992,340: 8833:1477
[294] Corrado OJ, Osman J, Davies RJ, Asthma and rhinitis after exposure to glutaraldehyde in endoscopy unitsIn Hum Toxicol,1986,5: 5:325-328.
[295] Nagy L, Orosz M, Occupational asthma due to hexachloropheneIn Thorax,1984,39: 8:630-631.
[296] Merget R, Topcu M, Friese K, Vormberg R, Fuchs T, Raulf-Heimsoth M, Breitstadt R, A cross-sectional study of workers in the chemical industry with occupational exposure to hexamethylenetetramineIn Int Arch Occup Environ Health,1999,72: 8:533-538.
[297] Gamble JF, McMichael AJ, Williams T, Battigelli M, Respiratory function and symptoms: an environmental-epidemiological study of rubber workers exposed to a phenolformaldehyde type resinIn Am Ind Hyg Assoc J,1976,37: 9:499-513.
[298] Bergman A, Svedberg U, Nilsson E, Contact urticaria with anaphylactic reactions caused by occupational exposure to iridium saltIn Contact Dermatitis,1995,32: 1:14-17.
[299] Baur X, Dewair M, Fruhmann G, Detection of immunologically sensitized isocyanate workers by RAST and intracutaneous skin testsIn J Allergy Clin Immunol,1984,73: 5 Pt 1:610-618.
[300] Piirila PL, Nordman H, Keskinen HM, Luukkonen R, Salo SP, Tuomi TO, Tuppurainen M, Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthmaIn Am J Respir Crit Care Med,2000,162: 2 Pt 1:516-522.
[301] O'Brien IM, Harries MG, Burge PS, Pepys J, Toluene di-isocyanate-induced asthma. I. Reactions to TDI, MDI, HDI and histamineIn Clin Allergy,1979,9: 1:1-6.
[302] Cartier A, Grammer L, Malo JL, Lagier F, Ghezzo H, Harris K, Patterson R, Specific serum antibodies against isocyanates: association with occupational asthmaIn J Allergy Clin Immunol,1989,84: 4 Pt 1:507-514.
[303] Tarlo SM, Liss GM, Yeung KS, Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measuresIn Occup Environ Med,2002,59: 1:58-62.
[304] Bernstein DI, Korbee L, Stauder T, Bernstein JA, Scinto J, Herd ZL, Bernstein IL, The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanatesIn J Allergy Clin Immunol,1993,92: 3:387-396.
[305] Liss GM, Bernstein DI, Moller DR, Gallagher JS, Stephenson RL, Bernstein IL, Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphenyldiisocyanate (MDI)In J Allergy Clin Immunol,1988,82: 1:55-61.
[306] Woellner RC, Hall S, Greaves I, Schoenwetter WF, Epidemic of asthma in a wood products plant using methylene diphenyl diisocyanateIn Am J Ind Med,1997,31: 1:56-63.
[307] Mapp CE, Corona PC, De Marzo N, Fabbri L, Persistent asthma due to isocyanates. A follow-up study of subjects with occupational asthma due to toluene diisocyanate (TDI)In Am Rev Respir Dis,1988,137: 6:1326-1329.
[308] Zammit-Tabona M, Sherkin M, Kijek K, Chan H, Chan-Yeung M, Asthma caused by diphenylmethane diisocyanate in foundry workers. Clinical, bronchial provocation, and immunologic studiesIn Am Rev Respir Dis,1983,128: 2:226-230.
[309] Perfetti L, Brame B, Ferrari M, Moscato G, Occupational asthma (OA) with sensitization to diphenylmethane diisocyanate (MDI) presenting at the onset like a reactive airways dysfunction syndrome (RADS)In Am J Ind Med,2003,44: 3:325-328.
[310] Hur GY, Koh DH, Choi GS, Park HJ, Choi SJ, Ye YM, Kim KS, Park HS, Clinical and immunologic findings of methylene diphenyl diisocyanate-induced occupational asthma in a car upholstery factoryIn Clin Exp Allergy,2008,38: 4:586-593.
[311] Vandenplas O, Malo JL, Dugas M, Cartier A, Desjardins A, Levesque J, Shaughnessy MA, Grammer LC, Hypersensitivity pneumonitis-like reaction among workers exposed to diphenylmethane [correction to piphenylmethane] diisocyanate (MDI)In Am Rev Respir Dis,1993,147: 2:338-346.
[312] Lemiere C, Malo JL, Boulet LP, Boutet M, Reactive airways dysfunction syndrome induced by exposure to a mixture containing isocyanate: functional and histopathologic behaviourIn Allergy,1996,51: 4:262-265.
[313] Belin L, Hjortsberg U, Wass U, Life-threatening pulmonary reaction to car paint containing a prepolymerized isocyanateIn Scand J Work Environ Health,1981,7: 4:310-311.
[314] Vandenplas O, Cartier A, Lesage J, Cloutier Y, Perreault G, Grammer LC, Shaughnessy MA, Malo JL, Prepolymers of hexamethylene diisocyanate as a cause of occupational asthmaIn J Allergy Clin Immunol,1993,91: 4:850-861.
[315] Clarke CW, Aldons PM, Isophorone diisocyanate induced respiratory disease (IPDI)In Aust N Z J Med,1981,11: 3:290-292.
[316] Kamat SR, Patel MH, Pradhan PV, Taskar SP, Vaidya PR, Kolhatkar VP, Gopalani JP, Chandarana JP, Dalal N, Naik M, Sequential respiratory, psychologic, and immunologic studies in relation to methyl isocyanate exposure over two years with model developmentIn Environ Health Perspect,1992,97:241-253.
[317] Baur X, Chen Z, Marczynski B, Respiratory diseases caused by occupational exposure to 1,5-naphthalene-diisocyanate (NDI): Results of workplace-related challenge tests and antibody analysesIn Am J Ind Med,2001,39: 4:369-372.
[318] Vijayan VK, Sankaran K, Relationship between lung inflammation, changes in lung function and severity of exposure in victims of the Bhopal tragedyIn Eur Respir J,1996,9: 10:1977-1982.
[319] Kamat SR, Mahashur AA, Tiwari AK, Potdar PV, Gaur M, Kolhatkar VP, Vaidya P, Parmar D, Rupwate R, Chatterjee TS, Early observations on pulmonary changes and clinical morbidity due to the isocyanate gas leak at BhopalIn J Postgrad Med,1985,31: 2:63-72.
[320] Harries MG, Burge PS, Samson M, Taylor AJ, Pepys J, Isocyanate asthma: respiratory symptoms due to 1,5-naphthylene di-isocyanateIn Thorax,1979,34: 6:762-766.
[321] Mehta PS, Mehta AS, Mehta SJ, Makhijani AB, Bhopal tragedy's health effectsIn A review of methyl isocyanate toxicity. JAMA,1990,264: 21:2781-2787.
[322] Alexandersson R, Gustafsson P, Hedenstierna G, Rosen G, Exposure to naphthalene-diisocyanate in a rubber plant: symptoms and lung functionIn Arch Environ Health,1986,41: 2:85-89.
[323] Baur X, Wieners D, Marczynski B, Late asthmatic reaction caused by naphthylene-1,5 diisocyanateIn Scand J Work Environ Health,2000,26: 1:78-80.
[324] Fuortes LJ, Kiken S, Makowsky M, An outbreak of naphthalene di-isocyanate-induced asthma in a plastics factoryIn Arch Environ Health,1995,50: 5:337-340.
[325] Seguin P, Allard A, Cartier A, Malo JL, Prevalence of occupational asthma in spray painters exposed to several types of isocyanates, including polymethylene polyphenylisocyanateIn J Occup Med,1987,29: 4:340-344.
[326] Butcher BT, Jones RN, O'Neil CE, Glindmeyer HW, Diem JE, Dharmarajan V, Weill H, Salvaggio JE, Longitudinal study of workers employed in the manufacture of toluene-diisocyanateIn Am Rev Respir Dis,1977,116: 3:411-421.
[327] Ott MG, Klees JE, Poche SL, Respiratory health surveillance in a toluene di-isocyanate production unit, 1967-97: clinical observations and lung function analysesIn Occup Environ Med,2000,57: 1:43-52.
[328] Omae K, Higashi T, Nakadate T, Tsugane S, Nakaza M, Sakurai H, Four-year follow-up of effects of toluene diisocyanate exposure on the respiratory system in polyurethane foam manufacturing workers. II. Four-year changes in the effects on the respiratory systemIn Int Arch Occup Environ Health,1992,63: 8:565-569.
[329] Marabini A, Brugnami G, Curradi F, Severini C, Siracusa A, The response to a specific bronchial provocation test and the evolution of occupational asthma. A longitudinal study in subjects with toluene diisocyanate-induced asthmaIn Med Lav,1994,85: 2:134-141.
[330] Karol MH, Tollerud DJ, Campbell TP, Fabbri L, Maestrelli P, Saetta M, Mapp CE, Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challengeIn Am J Respir Crit Care Med,1994,149: 3 Pt 1:611-615.
[331] Paggiaro P, Bacci E, Paoletti P, Bernard P, Dente FL, Marchetti G, Talini D, Menconi GF, Giuntini C, Bronchoalveolar lavage and morphology of the airways after cessation of exposure in asthmatic subjects sensitized to toluene diisocyanateIn Chest,1990,98: 3:536-542.
[332] Axford AT, McKerrow CB, Jones AP, Le Quesne PM, Accidental exposure to isocyanate fumes in a group of firemenIn Br J Ind Med,1976,33: 2:65-71.
[333] Vandenplas O, Cartier A, Lesage J, Perrault G, Grammer LC, Malo JL, Occupational asthma caused by a prepolymer but not the monomer of toluene diisocyanate (TDI)In J Allergy Clin Immunol,1992,89: 6:1183-1188.
[334] Luo JC, Nelsen KG, Fischbein A, Persistent reactive airway dysfunction syndrome after exposure to toluene diisocyanateIn Br J Ind Med,1990,47: 4:239-241.
[335] Piirila P, Estlander T, Hytonen M, Keskinen H, Tupasela O, Tuppurainen M, Rhinitis caused by ninhydrin develops into occupational asthmaIn Eur Respir J,1997,10: 8:1918-1921.
[336] Buick JB, Todd GR, Concomitant alveolitis and asthma following exposure to triphenylmethane triisocyanateIn Occup Med (Lond),1997,47: 8:504-506.
[337] Bourke SJ, Convery RP, Stenton SC, Malcolm RM, Hendrick DJ, Occupational asthma in an isothiazolinone manufacturing plantIn Thorax,1997,52: 8:746-748.
[338] Burge PS, Richardson MN, Occupational asthma due to indirect exposure to lauryl dimethyl benzyl ammonium chloride used in a floor cleanerIn Thorax,1994,49: 8:842-843.
[339] Belin L, Wass U, Audunsson G, Mathiasson L, Amines: possible causative agents in the development of bronchial hyperreactivity in workers manufacturing polyurethanes from isocyanatesIn Br J Ind Med,1983,40: 3:251-257.
[340] Estlander T, Kanerva L, Tupasela O, Keskinen H, Jolanki R, Immediate and delayed allergy to nickel with contact urticaria, rhinitis, asthma and contact dermatitisIn Clin Exp Allergy,1993,23: 4:306-310.
[341] Block GT, Yeung M, Asthma induced by nickelIn JAMA,1982,247: 11:1600-1602.
[342] Malo JL, Cartier A, Doepner M, Nieboer E, Evans S, Dolovich J, Occupational asthma caused by nickel sulfateIn J Allergy Clin Immunol,1982,69: 1 Pt 1:55-59.
[343] McConnell LH, Fink JN, Schlueter DP, Schmidt MG, Asthma caused by nickel sensitivityIn Ann Intern Med,1973,78: 6:888-890.
[344] Thickett KM, McCoach JS, Gerber JM, Sadhra S, Burge PS, Occupational asthma caused by chloramines in indoor swimming-pool airIn Eur Respir J,2002,19: 5:827-832.
[345] Mehta AJ, Henneberger PK, Toren K, Olin AC, Airflow limitation and changes in pulmonary function among bleachery workersIn Eur Respir J,2005,26: 1:133-139.
[346] Daenen M, Rogiers P, Van de Walle C, Rochette F, Demedts M, Nemery B, Occupational asthma caused by palladiumIn Eur Respir J,1999,13: 1:213-216.
[347] Silberman DE, Sorrell AH, Allergy in fur workers with special reference to paraphenylenediamineIn J Allergy,1959,30: 1:11-18.
[348] Moscato G, Pignatti P, Yacoub MR, Romano C, Spezia S, Perfetti L, Occupational asthma and occupational rhinitis in hairdressersIn Chest,2005,128: 5:3590-3598.
[349] Pankow W, Hein H, Bittner K, Wichert P, Persulfate asthma in hairdressersIn Pneumologie,1989,43: 3:173-175.
[350] Harth V, Raulf-Heimsoth M, Bruning T, Merget R, Isolated late asthmatic reaction after exposure to ammonium persulfate in a hairdresserIn Contact Dermatitis,2006,54: 1:62-63.
[351] Wrbitzky R, Drexler H, Letzel S, Early reaction type allergies and diseases of the respiratory passages in employees from persulphate productionIn Int Arch Occup Environ Health,1995,67: 6:413-417.
[352] Therond M, Geraut C, Dupas D, Gayoux CIn Pathology des persulfates alcalins,1989837-838.
[353] Parra FM, Igea JM, Quirce S, Ferrando MC, Martin JA, Losada E, Occupational asthma in a hairdresser caused by persulphate saltsIn Allergy,1992,47: 6:656-660.
[354] Munoz X, Cruz MJ, Orriols R, Bravo C, Espuga M, Morell F, Occupational asthma due to persulfate salts: diagnosis and follow-upIn Chest,2003,123: 6:2124-2129.
[355] Blainey AD, Ollier S, Cundell D, Smith RE, Davies RJ, Occupational asthma in a hairdressing salonIn Thorax,1986,41: 1:42-50.
[356] Gamboa PM, de la Cuesta CG, Garcia BE, Castillo JG, Oehling A, Late asthmatic reaction in a hairdresser, due to the inhalation of ammonium persulphate saltsIn Allergol Immunopathol (Madr),1989,17: 2:109-111.
[357] Baur X, Fruhmann G, von Liebe V, Occupational asthma and dermatitis after exposure to dusts of persulfate salts in two industrial workers (author's transl)In Respiration,1979,38: 3:144-150.
[358] Kammermeyer JK, Mathews KP, Hypersensitivity to phenylglycine acid chlorideIn J Allergy Clin Immunol,1973,52: 2:73-84.
[359] Wyatt JP, Allister CA, Occupational phosgene poisoning: a case report and reviewIn J Accid Emerg Med,1995,12: 3:212-213.
[360] Merget R, Kulzer R, Dierkes-Globisch A, Breitstadt R, Gebler A, Kniffka A, Artelt S, Koenig HP, Alt F, Vormberg R, Exposure-effect relationship of platinum salt allergy in a catalyst production plant: conclusions from a 5-year prospective cohort studyIn J Allergy Clin Immunol,2000,105: 2 Pt 1:364-370.
[361] Hnizdo E, Esterhuizen TM, Rees D, Lalloo UG, Occupational asthma as identified by the Surveillance of Work-related and Occupational Respiratory Diseases programme in South AfricaIn Clin Exp Allergy,2001,31: 1:32-39.
[362] Merget R, Reineke M, Rueckmann A, Bergmann EM, Schultze-Werninghaus G, Nonspecific and specific bronchial responsiveness in occupational asthma caused by platinum salts after allergen avoidanceIn Am J Respir Crit Care Med,1994,150: 4:1146-1149.
[363] Baker DB, Gann PH, Brooks SM, Gallagher J, Bernstein IL, Cross-sectional study of platinum salts sensitization among precious metals refinery workersIn Am J Ind Med,1990,18: 6:653-664.
[364] Venables KM, Dally MB, Nunn AJ, Stevens JF, Stephens R, Farrer N, Hunter JV, Stewart M, Hughes EG, Newman Taylor AJ, Smoking and occupational allergy in workers in a platinum refineryIn Bmj,1989,299: 6705:939-942.
[365] Pickering CA, Inhalation tests with chemical allergens: complex salts of platinumIn Proc R Soc Med,1972,65: 3:272-274.
[366] Stenton SC, Kelly CA, Walters EH, Hendrick DJ, Occupational asthma due to a repair process for polyethylene-coated electrical cablesIn J Soc Occup Med,1989,39: 1:33-34.
[367] Gannon PF, Burge PS, Benfield GF, Occupational asthma due to polyethylene shrink wrapping (paper wrapper's asthma)In Thorax,1992,47: 9:759
[368] Skerfving S, Akesson B, Simonsson BG, "Meat wrappers' asthma" caused by thermal degradation products of polyethyleneIn Lancet,1980,1: 8161:211
[369] Kennes B, Garcia-Herreros P, Dierckx P, Asthma from plexiglas powdersIn Clin Allergy,1981,11: 1:49-54.
[370] Atis S, Tutluoglu B, Levent E, Ozturk C, Tunaci A, Sahin K, Saral A, Oktay I, Kanik A, Nemery B, The respiratory effects of occupational polypropylene flock exposureIn Eur Respir J,2005,25: 1:110-117.
[371] Malo JL, Cartier A, Boulet LP, L'Archeveque J, Saint-Denis F, Bherer L, Courteau JP, Bronchial hyperresponsiveness can improve while spirometry plateaus two to three years after repeated exposure to chlorine causing respiratory symptomsIn Am J Respir Crit Care Med,1994,150: 4:1142-1145.
[372] Tuomainen A, Stark H, Seuri M, Hirvonen MR, Linnainmaa M, Sieppi A, Tukiainen H, Experimental PVC material challenge in subjects with occupational PVC exposureIn Environ Health Perspect,2006,114: 9:1409-1413.
[373] Lee HS, Ng TP, Ng YL, Phoon WH, Diurnal variation in peak expiratory flow rate among polyvinylchloride compounding workersIn Br J Ind Med,1991,48: 4:275-278.
[374] Wegman DH, Smith TJ, Eisen EA, Greaves IA, Fine LJ, Chelton CS, Respiratory effects of work in retail food stores. I. Methodology and exposure assignmentsIn Scand J Work Environ Health,1987,13: 3:203-208.
[375] Baser ME, Tockman MS, Kennedy TP, Pulmonary function and respiratory symptoms in polyvinylchloride fabrication workersIn Am Rev Respir Dis,1985,131: 2:203-208.
[376] Munoz X, Cruz MJ, Albanell M, Morell F, Occupational asthma in food packersIn Arch Bronconeumol,2003,39: 7:324-326.
[377] Lee HS, Yap J, Wang YT, Lee CS, Tan KT, Poh SC, Occupational asthma due to unheated polyvinylchloride resin dustIn Br J Ind Med,1989,46: 11:820-822.
[378] Sokol WN, Aelony Y, Beall GN, Meat-wrapper's asthma. A new syndrome?In Jama,1973,226: 6:639-641.
[379] Bright P, Burge PS, O'Hickey SP, Gannon PF, Robertson AS, Boran A, Occupational asthma due to chrome and nickel electroplatingIn Thorax,1997,52: 1:28-32.
[380] Hjortsberg U, Nise G, Orbaek P, Soes-Petersen U, Arborelius M, Bronchial asthma due to exposure to potassium aluminumtetrafluorideIn Scand J Work Environ Health,1986,12: 3:223
[381] Burge PS, Edge G, Hawkins R, White V, Taylor AJ, Occupational asthma in a factory making flux-cored solder containing colophonyIn Thorax,1981,36: 11:828-834.
[382] Burge PS, Harries MG, O'Brien I, Pepys J, Bronchial provocation studies in workers exposed to the fumes of electronic soldering fluxesIn Clin Allergy,1980,10: 2:137-149.
[383] Maestrelli P, Alessandri MV, Dal Vecchio L, Bartolucci GB, Cocheo V, Occupational asthma due to colophonyIn Med Lav,1985,76: 5:371-378.
[384] Weiss JS, Reactive airway dysfunction syndrome due to sodium azide inhalationIn Int Arch Occup Environ Health,1996,68: 6:469-471.
[385] Stenton SC, Dennis JH, Walters EH, Hendrick DJ, Asthmagenic properties of a newly developed detergent ingredient: sodium iso-nonanoyl oxybenzene sulphonateIn Br J Ind Med,1990,47: 6:405-410.
[386] Hendrick DJ, Connolly MJ, Stenton SC, Bird AG, Winterton IS, Walters EH, Occupational asthma due to sodium iso-nonanoyl oxybenzene sulphonate, a newly developed detergent ingredientIn Thorax,1988,43: 6:501-502.
[387] Ferguson H, Thomas KE, Ollier S, Davies RJ, Bronchial provocation testing of sodium iso-nonanoyl oxybenzene sulphonateIn Hum Exp Toxicol,1990,9: 2:83-89.
[388] Merget R, Korn M, Metabisulphite-induced occupational asthma in a radiographerIn Eur Respir J,2005,25: 2:386-388.
[389] Madsen J, Sherson D, Kjoller H, Hansen I, Rasmussen K, Occupational asthma caused by sodium disulphite in Norwegian lobster fishingIn Occup Environ Med,2004,61: 10:873-874.
[390] Malo JL, Cartier A, Desjardins A, Occupational asthma caused by dry metabisulphiteIn Thorax,1995,50: 5:585-586. Note: discussion 589
[391] Pougnet R, Lodde B, Lucas D, Jegaden D, Bell S, Dewitte JD, A case of occupational asthma from metabisulphite in a fishermanIn Int Marit Health,2010,62: 3:180-184.
[392] Steiner M, Scaife A, Semple S, Hulks G, Ayres JG, Sodium metabisulphite induced airways disease in the fishing and fish-processing industryIn Occup Med (Lond),2008,58: 8:545-550.
[393] Hayes JP, Lambourn L, Hopkirk JA, Durham SR, Taylor AJ, Occupational asthma due to styreneIn Thorax,1991,46: 5:396-397.
[394] Moscato G, Biscaldi G, Cottica D, Pugliese F, Candura S, Candura F, Occupational asthma due to styrene: two case reportsIn J Occup Med,1987,29: 12:957-960.
[395] Andersson E, Knutsson A, Hagberg S, Nilsson T, Karlsson B, Alfredsson L, Toren K, Incidence of asthma among workers exposed to sulphur dioxide and other irritant gasesIn Eur Respir J,2006,27: 4:720-725.
[396] Koksal N, Hasanoglu HC, Gokirmak M, Yildirim Z, Gultek A, Apricot sulfurization: an occupation that induces an asthma-like syndrome in agricultural environmentsIn Am J Ind Med,2003,43: 4:447-453.
[397] Harkonen H, Nordman H, Korhonen O, Winblad I, Long-term effects of exposure to sulfur dioxide. Lung function four years after a pyrite dust explosionIn Am Rev Respir Dis,1983,128: 5:890-893.
[398] Rosberg M, Asthma bronchiale caused by sulfthiazoleIn Acta Medica Scandinavica,1946,126:185-190.
[399] Eriksson KA, Levin JO, Sandstrom T, Lindstrom-Espeling K, Linden G, Stjernberg NL, Terpene exposure and respiratory effects among workers in Swedish joinery shopsIn Scand J Work Environ Health,1997,23: 2:114-120.
[400] Seaton A, Cherrie B, Turnbull J, Rubber glove asthmaIn Br Med J (Clin Res Ed),1988,296: 6621:531-532.
[401] Honda I, Kohrogi H, Ando M, Araki S, Ueno T, Futatsuka M, Ueda A, Occupational asthma induced by the fungicide tetrachloroisophthalonitrileIn Thorax,1992,47: 9:760-761.
[402] Baur X, Bittner C, Occupational obstructive airway diseases caused by the natural gas odorant tetrahydrothiophene-two case reportsIn Am J Ind Med,2009,52: 12:982-986.
[403] Vandenplas O, Delwiche JP, Auverdin J, Caroyer UM, Cangh FB, Asthma to tetramethrinIn Allergy,2000,55: 4:417-418.
[404] Shelton D, Urch B, Tarlo SM, Occupational asthma induced by a carpet fungicide-tributyl tin oxideIn J Allergy Clin Immunol,1992,90: 2:274-275.
[405] Bruckner HC, Extrinsic asthma in a tungsten carbide workerIn J Occup Med,1967,9: 10:518-519.
[406] Lee HS, Wang YT, Yeo CT, Tan KT, Ratnam KV, Occupational asthma due to tylosin tartrateIn Br J Ind Med,1989,46: 7:498-499.
[407] Frigas E, Filley WV, Reed CE, Asthma induced by dust from urea-formaldehyde foam insulating materialIn Chest,1981,79: 6:706-707.
[408] Bertrand JP, Simon V, Chau N, Associations of symptoms related to isocyanate, ureaformol, and formophenolic exposures with respiratory symptoms and lung function in coal minersIn Int J Occup Environ Health,2007,13: 2:181-187.
[409] Irsigler GB, Visser PJ, Spangenberg PA, Asthma and chemical bronchitis in vanadium plant workersIn Am J Ind Med,1999,35: 4:366-374.
[410] Pistelli R, Pupp N, Forastiere F, Agabiti N, Corbo GM, Tidei F, Perucci CA, Increase of nonspecific bronchial reactivity after occupational exposure to vanadiumIn Med Lav,1991,82: 3:270-275.
[411] Kielkowski D, Rees DIn Report on exposure and health, assessment of vanadium workers,1997
[412] Musk AW, Tees JG, Asthma caused by occupational exposure to vanadium compoundsIn Med J Aust,1982,1: 4:183-184.
[413] Malo JL, Cartier A, Occupational asthma due to fumes of galvanized metalIn Chest,1987,92: 2:375-377.
[414] Malo JL, Cartier A, Dolovich J, Occupational asthma due to zincIn Eur Respir J,1993,6: 3:447-450.
[415] Kawane H, Soejima R, Umeki S, Niki Y, Metal fume fever and asthmaIn Chest,1988,93: 5:1116-1117.
[416] Hambrook DW, Fink JN, Airbag asthma: a case report and review of the literatureIn Ann Allergy Asthma Immunol,2006,96: 2:369-372.
[417] Yang CY, Huang CC, Chiu HF, Chiu JF, Lan SJ, Ko YC, Effects of occupational dust exposure on the respiratory health of Portland cement workersIn J Toxicol Environ Health,1996,49: 6:581-588.
[418] Abrons HL, Petersen MR, Sanderson WT, Engelberg AL, Harber P, Symptoms, ventilatory function, and environmental exposures in Portland cement workersIn Br J Ind Med,1988,45: 6:368-375.
[419] Fell AK, Thomassen TR, Kristensen P, Egeland T, Kongerud J, Respiratory symptoms and ventilatory function in workers exposed to portland cement dustIn J Occup Environ Med,2003,45: 9:1008-1014.
[420] Al-Neaimi YI, Gomes J, Lloyd OL, Respiratory illnesses and ventilatory function among workers at a cement factory in a rapidly developing countryIn Occup Med (Lond),2001,51: 6:367-373.
[421] Ali BA, Ballal SG, Albar AA, Ahmed HO, Post-shift changes in pulmonary function in a cement factory in eastern Saudi ArabiaIn Occup Med (Lond),1998,48: 8:519-522.
[422] Kalacic I, Chronic nonspecific lung disease in cement workersIn Arch Environ Health,1973,26: 2:78-83.
[423] Mengesha YA, Bekele A, Relative chronic effects of different occupational dusts on respiratory indices and health of workers in three Ethiopian factoriesIn Am J Ind Med,1998,34: 4:373-380.
[424] Lockman LE, Case report: allergic contact dermatitis and new-onset asthma. Chromium exposure during leather tanningIn Can Fam Physician,2002,48:1907-1909.
[425] De Raeve H, Vandecasteele C, Demedts M, Nemery B, Dermal and respiratory sensitization to chromate in a cement floorerIn Am J Ind Med,1998,34: 2:169-176.
[426] Shirakawa T, Morimoto K, Brief reversible bronchospasm resulting from bichromate exposureIn Arch Environ Health,1996,51: 3:221-226.
[427] Nordby KC, Fell AK, Noto H, Eduard W, Skogstad M, Thomassen Y, Bergamaschi A, Kongerud J, Kjuus H, Exposure to thoracic dust, airway symptoms and lung function in cement production workersIn Eur Respir J,2011,38: 6:1278-1286.
[428] Piirila P, Espo T, Pfaffli P, Riihimaki V, Wolff H, Nordman H, Prolonged respiratory symptoms caused by thermal degradation products of freonsIn Scand J Work Environ Health,2003,29: 1:71-77.
[429] Lee J, Lee C, Kim CH, Uncontrolled occupational exposure to 1,1-dichloro-1-Fluoroethane (HCFC-141b) is associated with acute pulmonary toxicityIn Chest,2009,135: 1:149-155.
[430] Mirabelli MC, Zock JP, Plana E, Anto JM, Benke G, Blanc PD, Dahlman-Hoglund A, Jarvis DL, Kromhout H, Lillienberg L, Occupational risk factors for asthma among nurses and related healthcare professionals in an international studyIn Occup Environ Med,2007,64: 7:474-479.
[431] Rosenman KD, Reilly MJ, Schill DP, Valiante D, Flattery J, Harrison R, Reinisch F, Pechter E, Davis L, Tumpowsky CM, Cleaning products and work-related asthmaIn J Occup Environ Med,2003,45: 5:556-563.
[432] Tabar AI, Alvarez MJ, Acero S, Olaguibel JM, Garcia BE, Quirce S, Reactive airways dysfunction syndrome: two case reportsIn J Investig Allergol Clin Immunol,1998,8: 2:119-122.
[433] Vizcaya D, Mirabelli MC, Anto JM, Orriols R, Burgos F, Arjona L, Zock JP, A workforce-based study of occupational exposures and asthma symptoms in cleaning workersIn Occup Environ Med,2011,68: 12:914-919.
[434] Murphy DM, Fairman RP, Lapp NL, Morgan WK, Severe airway disease due to inhalation of fumes from cleansing agentsIn Chest,1976,69: 3:372-376.
[435] Mapp CE, Beghe B, Balboni A, Zamorani G, Padoan M, Jovine L, Baricordi OR, Fabbri LM, Association between HLA genes and susceptibility to toluene diisocyanate-induced asthmaIn Clin Exp Allergy,2000,30: 5:651-656.
[436] Jones RN, Hughes JM, Lehrer SB, Butcher BT, Glindmeyer HW, Diem JE, Hammad YY, Salvaggio J, Weill H, Lung function consequences of exposure and hypersensitivity in workers who process green coffee beansIn Am Rev Respir Dis,1982,125: 2:199-202.
[437] Zuskin E, Kanceljak B, Skuric Z, Butkovic D, Bronchial reactivity in green coffee exposureIn Br J Ind Med,1985,42: 6:415-420.
[438] Lemiere C, Malo JL, McCants M, Lehrer S, Occupational asthma caused by roasted coffee: immunologic evidence that roasted coffee contains the same antigens as green coffee, but at a lower concentrationIn J Allergy Clin Immunol,1996,98: 2:464-466.
[439] Johansen JP, Viskum S, Asthma associated with the handling of green coffee beansIn Ugeskr Laeger,1987,149: 42:2853
[440] Oldenburg M, Bittner C, Baur X, Health risks due to coffee dustIn Chest,2009,136: 2:536-544.
[441] Christiani DC, Wang XR, Pan LD, Zhang HX, Sun BX, Dai H, Eisen EA, Wegman DH, Olenchock SA, Longitudinal changes in pulmonary function and respiratory symptoms in cotton textile workers. A 15-yr follow-up studyIn Am J Respir Crit Care Med,2001,163: 4:847-853.
[442] Latza U, Oldenburg M, Baur X, Endotoxin exposure and respiratory symptoms in the cotton textile industryIn Arch Environ Health,2004,59: 10:519-525.
[443] Oldenburg M, Latza U, Baur X, Exposure-response relationship between endotoxin exposure and lung function impairment in cotton textile workersIn Int Arch Occup Environ Health,2007,80: 5:388-395.
[444] Hayes GB, Ye TT, Lu PL, Dai HL, Christiani DC, Respiratory disease in cotton textile workers: epidemiologic assessment of small airway functionIn Environ Res,1994,66: 1:31-43.
[445] Wang XR, Pan LD, Zhang HX, Sun BX, Dai HL, Christiani DC, A longitudinal observation of early pulmonary responses to cotton dustIn Occup Environ Med,2003,60: 2:115-121.
[446] Li D, Zhong YN, Rylander R, Ma QY, Zhou XY, Longitudinal study of the health of cotton workersIn Occup Environ Med,1995,52: 5:328-331.
[447] Mberikunashe J, Banda S, Chadambuka A, Gombe NT, Shambira G, Tshimanga M, Matchaba-Hove R, Prevalence and risk factors for obstructive respiratory conditions among textile industry workers in Zimbabwe, 2006In Pan Afr Med J,2010,6:1
[448] Hendy MS, Beattie BE, Burge PS, Occupational asthma due to an emulsified oil mistIn Br J Ind Med,1985,42: 1:51-54.
[449] Keskinen H, Nordman H, Terho EO, ECG ink as a cause of asthmaIn Allergy,1981,36: 4:275-276.
[450] Rodenstein D, Stanescu DC, Bronchial asthma following exposure to ECG inkIn Ann Allergy,1982,48: 6:351-352.
[451] Milton DK, Wypij D, Kriebel D, Walters MD, Hammond SK, Evans JS, Endotoxin exposure-response in a fiberglass manufacturing facilityIn Am J Ind Med,1996,29: 1:3-13.
[452] Jaakkola JJ, Piipari R, Jaakkola MS, Occupation and asthma: a population-based incident case-control studyIn Am J Epidemiol,2003,158: 10:981-987.
[453] Lambourn EM, Hayes JP, McAllister WA, Taylor AJ, Occupational asthma due to EPO 60In Br J Ind Med,1992,49: 4:294-295.
[454] Cockcroft DW, Cartier A, Jones G, Tarlo SM, Dolovich J, Hargreave FE, Asthma caused by occupational exposure to a furan-based binder systemIn J Allergy Clin Immunol,1980,66: 6:458-463.
[455] Chan-Yeung M, Schulzer M, MacLean L, Dorken E, Grzybowski S, Epidemiologic health survey of grain elevator workers in British ColumbiaIn Am Rev Respir Dis,1980,121: 2:329-338.
[456] Williams N, Skoulas A, Merriman JE, Exposure to Grain Dust. I. a Survey of the EffectsIn J Occup Med,1964,6:319-329.
[457] Skoulas A, Williams N, Merriman JE, Exposure to Grain Dust. Ii. a Clinical Study of the EffectsIn J Occup Med,1964,6:359-372.
[458] Baur X, Preisser A, Wegner R, Asthma due to grain dustIn Pneumologie,2003,57: 6:335-339.
[459] Chan-Yeung M, Dimich-Ward H, Enarson DA, Kennedy SM, Five cross-sectional studies of grain elevator workersIn Am J Epidemiol,1992,136: 10:1269-1279.
[460] Ye TT, Huang JX, Shen YE, Lu PL, Christiani DC, Respiratory symptoms and pulmonary function among Chinese rice-granary workersIn Int J Occup Environ Health,1998,4: 3:155-159.
[461] Dube D, Puruckherr M, Byrd RP, Roy TM, Reactive airways dysfunction syndrome following metal fume feverIn Tenn Med,2002,95: 6:236-238.
[462] Zacharisen MC, Kadambi AR, Schlueter DP, Kurup VP, Shack JB, Fox JL, Anderson HA, Fink JN, The spectrum of respiratory disease associated with exposure to metal working fluidsIn J Occup Environ Med,1998,40: 7:640-647.
[463] Wieslander G, Janson C, Norback D, Bjornsson E, Stalenheim G, Edling C, Occupational exposure to water-based paints and self-reported asthma, lower airway symptoms, bronchial hyperresponsiveness, and lung functionIn Int Arch Occup Environ Health,1994,66: 4:261-267.
[464] Temel O, Sakar Coskun A, Yaman N, Sarioglu N, Alkac C, Konyar I, Ozgen Alpaydin A, Celik P, Cengiz Ozyurt B, Keskin E, Occupational asthma in welders and paintersIn Tuberk Toraks,2010,58: 1:64-70.
[465] Baur X, Schneider EM, Wieners D, Czuppon AB, Occupational asthma to perfumeIn Allergy,1999,54: 12:1334-1335.
[466] Lings S, Pesticide lung: a pilot investigation of fruit-growers and farmers during the spraying seasonIn Br J Ind Med,1982,39: 4:370-376.
[467] Boers D, van Amelsvoort L, Colosio C, Corsini E, Fustinoni S, Campo L, Bosetti C, La Vecchia C, Vergieva T, Tarkowski M, Asthmatic symptoms after exposure to ethylenebisdithiocarbamates and other pesticides in the Europit field studiesIn Hum Exp Toxicol,2008,27: 9:721-727.
[468] Ng TP, Lee HS, Malik MA, Chee CB, Cheong TH, Wang YT, Asthma in chemical workers exposed to aliphatic polyaminesIn Occup Med (Lond),1995,45: 1:45-48.
[469] Cartier A, Vandenplas O, Grammer LC, Shaughnessy MA, Malo JL, Respiratory and systemic reaction following exposure to heated electrostatic polyester paintIn Eur Respir J,1994,7: 3:608-611.
[470] Zuskin E, Mustajbegovic J, Schachter EN, Kern J, Budak A, Godnic-Cvar J, Respiratory findings in synthetic textile workersIn Am J Ind Med,1998,33: 3:263-273.
[471] Burge PS, Scott JA, McCoach J, Occupational asthma caused by aluminumIn Allergy,2000,55: 8:779-780.
[472] Chan-Yeung M, Wong R, MacLean L, Tan F, Schulzer M, Enarson D, Martin A, Dennis R, Grzybowski S, Epidemiologic health study of workers in an aluminum smelter in British Columbia. Effects on the respiratory systemIn Am Rev Respir Dis,1983,127: 4:465-469.
[473] Desjardins A, Bergeron JP, Ghezzo H, Cartier A, Malo JL, Aluminium potroom asthma confirmed by monitoring of forced expiratory volume in one secondIn Am J Respir Crit Care Med,1994,150: 6 Pt 1:1714-1717.
[474] Musk AW, de Klerk NH, Beach JR, Fritschi L, Sim MR, Benke G, Abramson M, McNeil JJ, Respiratory symptoms and lung function in alumina refinery employeesIn Occup Environ Med,2000,57: 4:279-283.
[475] O'Donnell TV, Welford B, Coleman ED, Potroom asthma: New Zealand experience and follow-upIn Am J Ind Med,1989,15: 1:43-49.
[476] Saric M, Godnic-Cvar J, Gomzi M, Stilinovic L, The role of atopy in potroom workers' asthmaIn Am J Ind Med,1986,9: 3:239-242.
[477] Sorgdrager B, de Looff AJ, de Monchy JG, Pal TM, Dubois AE, Rijcken B, Occurrence of occupational asthma in aluminum potroom workers in relation to preventive measuresIn Int Arch Occup Environ Health,1998,71:53-59.
[478] Sorgdrager B, de Looff AJ, Pal TM, van Dijk FJ, de Monchy JG, Factors affecting FEV1 in workers with potroom asthma after their removal from exposureIn Int Arch Occup Environ Health,2001,74: 1:55-58.
[479] Blomqvist A, Duzakin-Nystedt M, Ohlson CG, Andersson L, Jonsson B, Nielsen J, Welinder H, Airways symptoms, immunological response and exposure in powder paintingIn Int Arch Occup Environ Health,2005,78: 2:123-131.
[480] Nakano Y, Tsuchiya T, Hirose K, Chida K, Occupational asthma caused by pyrazolone derivative used in silver halide photographic paperIn Chest,2000,118: 1:246-248.
[481] Alanko K, Keskinen H, Bjorksten F, Ojanen S, Immediate-type hypersensitivity to reactive dyesIn Clin Allergy,1978,8: 1:25-31.
[482] Nilsson R, Nordlinder R, Wass U, Meding B, Belin L, Asthma, rhinitis, and dermatitis in workers exposed to reactive dyesIn Br J Ind Med,1993,50: 1:65-70.
[483] Park HS, Lee MK, Hong CS, Reactive dye induced occupational asthma without nonspecific bronchial hyperreactivityIn Yonsei Med J,1990,31: 2:98-102.
[484] Park HS, Lee MK, Kim BO, Lee KJ, Roh JH, Moon YH, Hong CS, Clinical and immunologic evaluations of reactive dye-exposed workersIn J Allergy Clin Immunol,1991,87: 3:639-649.
[485] Romano C, Sulotto F, Pavan I, Chiesa A, Scansetti G, A new case of occupational asthma from reactive dyes with severe anaphylactic response to the specific challengeIn Am J Ind Med,1992,21: 2:209-216.
[486] Forrester BG, Reactive airways dysfunction syndrome: occurrence after exposure to a refractory ceramic fiber-phosphoric acid binder mixtureIn South Med J,1997,90: 4:447-450.
[487] Lemasters GK, Lockey JE, Levin LS, McKay RT, Rice CH, Horvath EP, Papes DM, Lu JW, Feldman DJ, An industry-wide pulmonary study of men and women manufacturing refractory ceramic fibersIn Am J Epidemiol,1998,148: 9:910-919.
[488] Almeida AG, Duarte R, Mieiro L, Paiva AC, Rodrigues AM, Almeida MH, Barbara C, Pulmonary function in Portuguese firefightersIn Rev Port Pneumol,2007,13: 3:349-364.
[489] Moisan TC, Prolonged asthma after smoke inhalation: a report of three cases and a review of previous reportsIn J Occup Med,1991,33: 4:458-461.
[490] Greven F, Krop E, Spithoven J, Rooyackers J, Kerstjens H, Heederik D, Lung function, bronchial hyperresponsiveness, and atopy among firefightersIn Scand J Work Environ Health,2011,37: 4:325-331.
[491] Kelsall HL, Sim MR, Forbes AB, Glass DC, McKenzie DP, Ikin JF, Abramson MJ, Blizzard L, Ittak P, Symptoms and medical conditions in Australian veterans of the 1991 Gulf War: relation to immunisations and other Gulf War exposuresIn Occup Environ Med,2004,61: 12:1006-1013.
[492] Ekici A, Ekici M, Kurtipek E, Akin A, Arslan M, Kara T, Apaydin Z, Demir S, Obstructive airway diseases in women exposed to biomass smokeIn Environ Res,2005,99: 1:93-98.
[493] Burge PS, Perks W, O'Brien IM, Hawkins R, Green M, Occupational asthma in an electronics factoryIn Thorax,1979,34: 1:13-18.
[494] Lee HS, Koh D, Chia HP, Phoon WH, Symptoms, lung function, and diurnal variation in peak expiratory flow rate among female solderers in the electronics industryIn Am J Ind Med,1994,26: 5:613-619.
[495] Stevens JJ, Asthma due to soldering flux: a polyether alcohol-polypropylene glycol mixtureIn Ann Allergy,1976,36: 6:419-422.
[496] Cakmak A, Ekici A, Ekici M, Arslan M, Iteginli A, Kurtipek E, Kara T, Respiratory findings in gun factory workers exposed to solventsIn Respir Med,2004,98: 1:52-56.
[497] Ebbehoj NE, Hein HO, Suadicani P, Gyntelberg F, Occupational organic solvent exposure, smoking, and prevalence of chronic bronchitis-an epidemiological study of 3387 menIn J Occup Environ Med,2008,50: 7:730-735.
[498] Tarlo SM, Occupational asthma induced by tall oil in the rubber tyre industryIn Clin Exp Allergy,1992,22: 1:99-101.
[499] Bayeux-Dunglas MC, Deparis P, Touati MA, Ameille J, Occupational asthma in a teacher after repeated exposure to tear gasIn Rev Mal Respir,1999,16: 4:558-559.
[500] Hill AR, Silverberg NB, Mayorga D, Baldwin HE, Medical hazards of the tear gas CS. A case of persistent, multisystem, hypersensitivity reaction and review of the literatureIn Medicine (Baltimore),2000,79: 4:234-240.
[501] Hu H, Christiani D, Reactive airways dysfunction after exposure to teargasIn Lancet,1992,339: 8808:1535
[502] Roth VS, Franzblau A, RADS after exposure to a riot-control agent: a case reportIn J Occup Environ Med,1996,38: 9:863-865.
[503] El-Zein M, Malo JL, Infante-Rivard C, Gautrin D, Incidence of probable occupational asthma and changes in airway calibre and responsiveness in apprentice weldersIn Eur Respir J,2003,22: 3:513-518.
[504] Jafari AJ, Assari MJ, Respiratory effects from work-related exposure to welding fumes in Hamadan, IranIn Arch Environ Health,2004,59: 3:116-120.
[505] Nakadate T, Aizawa Y, Yagami T, Zheg YQ, Kotani M, Ishiwata K, Change in obstructive pulmonary function as a result of cumulative exposure to welding fumes as determined by magnetopneumography in Japanese arc weldersIn Occup Environ Med,1998,55: 10:673-677.
[506] Beach JR, Dennis JH, Avery AJ, Bromly CL, Ward RJ, Walters EH, Stenton SC, Hendrick DJ, An epidemiologic investigation of asthma in weldersIn Am J Respir Crit Care Med,1996,154: 5:1394-1400.
[507] Hannu T, Piipari R, Toskala E, Immediate hypersensitivity type of occupational laryngitis in a welder exposed to welding fumes of stainless steelIn Am J Ind Med,2006,49: 5:402-405.
[508] Karjalainen A, Martikainen R, Oksa P, Saarinen K, Uitti J, Incidence of asthma among Finnish construction workersIn J Occup Environ Med,2002,44: 8:752-757.
[509] Contreras GR, Chan-Yeung M, Bronchial reactions to exposure to welding fumesIn Occup Environ Med,1997,54: 11:836-839.
[510] Hannu T, Piipari R, Kasurinen H, Keskinen H, Tuppurainen M, Tuomi T, Occupational asthma due to manual metal-arc welding of special stainless steelsIn Eur Respir J,2005,26: 4:736-739.
[511] Vandenplas O, Delwiche JP, Vanbilsen ML, Joly J, Roosels D, Occupational asthma caused by aluminium weldingIn Eur Respir J,1998,11: 5:1182-1184.
[512] Vandenplas O, Dargent F, Auverdin JJ, Boulanger J, Bossiroy JM, Roosels D, Van de Weyer R, Occupational asthma due to gas metal arc welding on mild steelIn Thorax,1995,50: 5:587-588. Note: discussion 589
[513] Keskinen H, Kalliomaki PL, Alanko K, Occupational asthma due to stainless steel welding fumesIn Clin Allergy,1980,10: 2:151-159.
[514] Halvani GH, Zare M, Halvani A, Barkhordari A, Evaluation and comparison of respiratory symptoms and lung capacities in tile and ceramic factory workers of YazdIn Arh Hig Rada Toksikol,2008,59: 3:197-204.
[515] Neghab M, Zadeh JH, Fakoorziba MR, Respiratory toxicity of raw materials used in ceramic productionIn Ind Health,2009,47: 1:64-69.
[516] Oliver LC, Miracle-McMahill H, Littman AB, Oakes JM, Gaita RR, Respiratory symptoms and lung function in workers in heavy and highway construction: a cross-sectional studyIn Am J Ind Med,2001,40: 1:73-86.
[517] Kaukiainen A, Martikainen R, Riala R, Reijula K, Tammilehto L, Work tasks, chemical exposure and respiratory health in construction paintingIn Am J Ind Med,2008,51: 1:1-8.
[518] Walusiak J, Krawczyk-Adamus P, Hanke W, Wittczak T, Palczynski C, Small nonspecialized farming as a protective factor against immediate-type occupational respiratory allergy?In Allergy,2004,59: 12:1294-1300.
[519] Gomez MI, Hwang SA, Lin S, Stark AD, May JJ, Hallman EM, Prevalence and predictors of respiratory symptoms among New York farmers and farm residentsIn Am J Ind Med,2004,46: 1:42-54.
[520] Dosman JA, Graham BL, Hall D, Van Loon P, Bhasin P, Froh F, Respiratory symptoms and pulmonary function in farmersIn J Occup Med,1987,29: 1:38-43.
[521] Rask-Andersen A, Asthma increase among farmers: a 12-year follow-upIn Ups J Med Sci,2011,116: 1:60-71.
[522] Portengen L, Preller L, Tielen M, Doekes G, Heederik D, Endotoxin exposure and atopic sensitization in adult pig farmersIn J Allergy Clin Immunol,2005,115: 4:797-802.
[523] Monso E, Riu E, Radon K, Magarolas R, Danuser B, Iversen M, Morera J, Nowak D, Chronic obstructive pulmonary disease in never-smoking animal farmers working inside confinement buildingsIn Am J Ind Med,2004,46: 4:357-362.
[524] Radon K, Weber C, Iversen M, Danuser B, Pedersen S, Nowak D, Exposure assessment and lung function in pig and poultry farmersIn Occup Environ Med,2001,58: 6:405-410.
[525] Hansen ES, A cohort mortality study of foundry workersIn Am J Ind Med,1997,32: 3:223-233.
[526] Hahn R, Beck B, Incidence of chronic bronchitis in foundry workersIn Z Erkr Atmungsorgane,1986,166: 3:267-273.
[527] Pechter E, Davis LK, Tumpowsky C, Flattery J, Harrison R, Reinisch F, Reilly MJ, Rosenman KD, Schill DP, Valiante D, Work-related asthma among health care workers: surveillance data from California, Massachusetts, Michigan, and New Jersey, 1993-1997In Am J Ind Med,2005,47: 3:265-275.
[528] Arif AA, Delclos GL, Association between cleaning-related chemicals and work-related asthma and asthma symptoms among healthcare professionalsIn Occup Environ Med,2012,69: 1:35-40.
[529] Arif AA, Delclos GL, Serra C, Occupational exposures and asthma among nursing professionalsIn Occup Environ Med,2009,66: 4:274-278.
[530] Bala S, Tabaku A, Chronic obstructive pulmonary disease in iron-steel and ferrochrome industry workersIn Cent Eur J Public Health,2010,18: 2:93-98.
[531] Rylander R, Carvalheiro MF, Airways inflammation among workers in poultry housesIn Int Arch Occup Environ Health,2006,79: 6:487-490.
[532] Hagmar L, Schutz A, Hallberg T, Sjoholm A, Health effects of exposure to endotoxins and organic dust in poultry slaughter-house workersIn Int Arch Occup Environ Health,1990,62: 2:159-164.
[533] Danuser B, Wyss C, Hauser R, von Planta U, Folsch D, Lung function and symptoms in employees of poultry farmsIn Soz Praventivmed,1988,33: 6:286-291.
[534] King BS, Page EH, Mueller CA, Dollberg DD, Gomez KE, Warren AM, Eye and respiratory symptoms in poultry processing workers exposed to chlorine by-productsIn Am J Ind Med,2006,49: 2:119-126.
[535] Borghetti C, Magarolas R, Badorrey I, Radon K, Morera J, Monso E, Sensitization and occupational asthma in poultry workersIn Med Clin (Barc),2002,118: 7:251-255.
[536] Perfetti L, Cartier A, Malo JL, Occupational asthma in poultry-slaughterhouse workersIn Allergy,1997,52: 5:594-595.
[537] Vogelzang PF, van der Gulden JW, Folgering H, Heederik D, Tielen MJ, van Schayck CP, Longitudinal changes in bronchial responsiveness associated with swine confinement dust exposureIn Chest,2000,117: 5:1488-1495.
[538] Reynolds SJ, Donham KJ, Whitten P, Merchant JA, Burmeister LF, Popendorf WJ, Longitudinal evaluation of dose-response relationships for environmental exposures and pulmonary function in swine production workersIn Am J Ind Med,1996,29: 1:33-40.
[539] Schwartz DA, Donham KJ, Olenchock SA, Popendorf WJ, Van Fossen DS, Burmeister LF, Merchant JA, Determinants of longitudinal changes in spirometric function among swine confinement operators and farmersIn Am J Respir Crit Care Med,1995,151: 1:47-53.
[540] Vogelzang PF, van der Gulden JW, Folgering H, Kolk JJ, Heederik D, Preller L, Tielen MJ, van Schayck CP, Endotoxin exposure as a major determinant of lung function decline in pig farmersIn Am J Respir Crit Care Med,1998,157: 1:15-18.
[541] Banauch GI, Alleyne D, Sanchez R, Olender K, Cohen HW, Weiden M, Kelly KJ, Prezant DJ, Persistent hyperreactivity and reactive airway dysfunction in firefighters at the World Trade CenterIn Am J Respir Crit Care Med,2003,168: 1:54-62.
[542] Banauch GI, Dhala A, Prezant DJ, Pulmonary disease in rescue workers at the World Trade Center siteIn Curr Opin Pulm Med,2005,11: 2:160-168.
[543] Banauch GI, Hall C, Weiden M, Cohen HW, Aldrich TK, Christodoulou V, Arcentales N, Kelly KJ, Prezant DJ, Pulmonary function after exposure to the World Trade Center collapse in the New York City Fire DepartmentIn Am J Respir Crit Care Med,2006,174: 3:312-319.
[544] Herbstman JB, Frank R, Schwab M, Williams DL, Samet JM, Breysse PN, Geyh AS, Respiratory effects of inhalation exposure among workers during the clean-up effort at the World Trade Center disaster siteIn Environ Res,2005,99: 1:85-92.
[545] Salzman SH, Moosavy FM, Miskoff JA, Friedmann P, Fried G, Rosen MJ, Early respiratory abnormalities in emergency services police officers at the World Trade Center siteIn J Occup Environ Med,2004,46: 2:113-122.
[546] Mauer MP, Cummings KR, Hoen R, Long-term respiratory symptoms in World Trade Center respondersIn Occup Med (Lond),2010,60: 2:145-151.
[547] Feinstein AR, Horwitz RI, Problems in the "evidence" of "evidence-based medicine"In Am J Med,1997,103: 6:529-535.
[548] Miettinen OS, Evidence in medicine: invited commentaryIn Cmaj,1998,158: 2:215-221.
[549] Miettinen OS, Evidence-based medicine, case-based medicine; scientific medicine, quasi-scientific medicine. Commentary on Tonelli (2006), Integrating evidence into clinical practice: an alternative to evidence-based approaches. Journal of Evaluation in Clinical Practice 12, 248-256In J Eval Clin Pract,2006,12: 3:260-264.
[550] Tobin MJ, Counterpoint: evidence-based medicine lacks a sound scientific baseIn Chest,2008,133: 5:1071-1074. Note: discussion 1074-1077
[551] Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, Bossuyt PM, Empirical evidence of design-related bias in studies of diagnostic testsIn Jama,1999,282: 11:1061-1066.
[552] Beach J, Rowe BH, Blitz S, Crumley E, Hooton N, Russell K, Spooner C, Klassen TIn Diagnosis and management of work-related asthma. Evidence Report/Technology Assessment No 129 U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality, Rockville,2005 Note: http://www.ahrq.gov/downloads/pub/evidence/pdf/asthmawork/asthwork.pdf
[553] Kunz R, Burnand B, Schunemann HJ, The GRADE System. An international approach to standardize the graduation of evidence and recommendations in guidelinesIn Internist (Berl),2008,49: 6:673-680.
[554] West S, King V, CT S, Lohr KN, McKoy N, Sutton SF, Lux LIn Systems to rate the strength of scientific evidence, vol. 47 Agency for Healthcare, Research and Quality, Rockville,2002 Note: http://archive.ahrq.gov/clinic/tp/strengthtp.htm
[555] Quint J, Beckett WS, Campleman SL, Sutton P, Prudhomme J, Flattery J, Harrison R, Cowan B, Kreutzer R, Primary prevention of occupational asthma: identifying and controlling exposures to asthma-causing agentsIn Am J Ind Med,2008,51: 7:477-491.
[556] AbuDhaise BA, Rabi AZ, Al Zwairy MA, El Hader AF, El Qaderi S, Pulmonary manifestations in cement workers in JordanIn Int J Occup Med Environ Health,1997,10: 4:417-428.
[557] Salvi SS, Barnes PJ, Chronic obstructive pulmonary disease in non-smokersIn Lancet,2009,374: 9691:733-743.
[558] Blanc FX, Coirault C, Oliviero P, Lecarpentier Y, Relaxation of tracheal smooth muscle is impaired in innate airway hyperresponsivenessIn Eur Respir J,2009,34: 2:417-424.
[559] Balmes JR, Nowak D, COPD caused by occupational exposureIn COPD Edited by: Donner CF, Carone M Clinical publishing, Oxford,200785-95.
[560] Blanc PD, Toren K, Occupation in chronic obstructive pulmonary disease and chronic bronchitis: an updateIn Int J Tuberc Lung Dis,2007,11: 3:251-257.
[561] Toren K, Balmes J, Chronic obstructive pulmonary disease: does occupation matter?In Am J Respir Crit Care Med,2007,176: 10:951-952.
[562] Bardana EJ, Reactive airways dysfunction syndrome (RADS): guidelines for diagnosis and treatment and insight into likely prognosisIn Ann Allergy Asthma Immunol,1999,83: 6 Pt 2:583-586.
[563] Vandenplas O, Malo JL, Definitions and types of work-related asthma: a nosological approachIn Eur Respir J,2003,21: 4:706-712.
[564] Blanc PD, Menezes AM, Plana E, Mannino DM, Hallal PC, Toren K, Eisner MD, Zock JP, Occupational exposures and COPD: an ecological analysis of international dataIn Eur Respir J,2009,33: 2:298-304.
[565] Malo JL, Chan-Yeung M, Agents causing occupational asthmaIn J Allergy Clin Immunol,2009,123: 3:545-550.
[566] Cullinan P, Irritant-induced asthma from work. What happens next?In Am J Respir Crit Care Med,2009,179: 10:857-858.
[567] Tarlo SM, Boulet LP, Cartier A, Cockcroft D, Cote J, Hargreave FE, Holness L, Liss G, Malo JL, Chan-Yeung M, Canadian Thoracic Society guidelines for occupational asthmaIn Can Respir J,1998,5: 4:289-300.
[568] Ernst P, Fitzgerald JM, Spier S, Canadian Asthma Consensus Conference Summary of recommendationsIn Can Respir J,1996,3: 2:89-101.
[569] Newman Taylor AJ, Cullinan P, Burge PS, Nicholson P, Boyle C, BOHRF guidelines for occupational asthmaIn Thorax,2005,60: 5:364-366.
[570] Heederik D, van Rooy F, Exposure assessment should be integrated in studies on the prevention and management of occupational asthmaIn Occup Environ Med,2008,65: 3:149-150.
[571] Venables KM, Prevention of occupational asthmaIn Eur Respir J,1994,7: 4:768-778.
[572] Vineis P, Evidence-based primary prevention?In Scand J Work Environ Health,2000,26: 5:443-448.
[573] Drummond MF, Stoddart GL, Torrance GWIn Method of economic evaluation of health care programes Oxford Medical Publications, Oxford,1987
[574] Heederik D, Henneberger PK, Redlich CA, Primary prevention: exposure reduction, skin exposure and respiratory protectionIn Eur Respir Rev,2012,21: 124:112-124.
[575] Schoenbach V, Wayne DIn Understanding the fundamentals of epidemiology: an evolving text. Chapter 8: Analytic study designs epidemiolog.net, Chapel Hill,2000 Note: http://www.epidemiolog.net/evolving/TableOfContents.htm
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2012 Baur et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Doc number: 19
Abstract
Background: Respiratory irritants represent a major cause of occupational obstructive airway diseases. We provide an overview of the evidence related to irritative agents causing occupational asthma or occupational COPD.
Methods: We searched MEDLINE via PubMed. Reference lists of relevant reviews were also screened. The SIGN grading system was used to rate the quality of each study. The modified RCGP three-star system was used to grade the body of evidence for each irritant agent regarding its causative role in either occupational asthma or occupational COPD.
Results: A total of 474 relevant papers were identified, covering 188 individual agents, professions or work-sites. The focus of most of the studies and the predominant diagnosis was occupational asthma, whereas occupational COPD arose only incidentally.
The highest level assigned using the SIGN grading was 2+ (well-conducted systematic review, cohort or case-control study with a low risk of confounding or bias). According to the modified RCGP three-star grading, the strongest evidence of association with an individual agent, profession or work-site ("**") was found for 17 agents or work-sites, including benzene-1,2,4-tricarboxylicacid-1,2-anhydride, chlorine, platinum salt, isocyanates, cement dust, grain dust, animal farming, environmental tobacco smoke, welding fumes or construction work. Phthalic anhydride, glutaraldehyde, sulphur dioxide, cotton dust, cleaning agents, potrooms, farming (various), foundries were found to be moderately associated with occupational asthma or occupational COPD ("*[+]").
Conclusion: This study let us assume that irritant-induced occupational asthma and especially occupational COPD are considerably underreported. Defining the evidence of the many additional occupational irritants for causing airway disorders will be the subject of continued studies with implications for diagnostics and preventive measures.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer




